PRR12-Related Neuroocular Syndrome

Mendelian MONDO:0971007 Pathograph 25 Show in embeddings browser hereditary disease syndromic microphthalmia

PRR12-related neuroocular syndrome (neuroocular syndrome 1, NOC1) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous loss-of-function variants in PRR12, which encodes a proline-rich, chromatin-associated nuclear protein expressed in the developing brain and visual system. Developmental impairment is the one near-constant finding; the ocular phenotype is strikingly variable, spanning the anophthalmia-microphthalmia-coloboma (MAC) spectrum together with anterior segment dysgenesis (Peters anomaly, stellate iris pattern, iris coloboma) and optic nerve anomalies, and is present in only about half of reported individuals. Additional common features are hypotonia, congenital heart defects, growth failure or short stature, kidney anomalies, microcephaly, dysmorphic features, and neuropsychiatric problems including autism, ADHD, and anxiety. The disorder was delineated only in 2018-2021 and fewer than forty individuals have been reported, so the phenotypic boundaries are still being defined.

Ask OpenScientist

Ask a research question about PRR12-Related Neuroocular Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

👪

Inheritance

Autosomal dominant inheritance HP:0000006

Disease results from a single heterozygous loss-of-function PRR12 allele. Most reported variants arose de novo, but the first dominantly transmitted allele, a splice-site variant segregating from an affected mother to her affected daughter, confirms germline transmission, and somatic mosaicism has been documented in at least one individual. Recurrence risk for unaffected parents of a de novo case is low but not zero because parental germline mosaicism cannot be excluded.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:29556724 SUPPORT Human Clinical

"Here we report on three unrelated patients with heterozygous de novo apparent loss-of-function mutations in PRR12 detected by clinical whole exome sequencing"

The founding series establishes heterozygous de novo PRR12 variants as the disease mechanism, that is, dominant inheritance.

PMID:33314030 SUPPORT Human Clinical

"We identified four novel pathogenic loss-of-function alleles in PRR12 in families affected by complex microphthalmia and/or Peters anomaly, including two de novo, the first dominantly transmitted allele, as well as the first splicing variant."

Documents the first parent-to-child transmitted PRR12 allele, confirming autosomal dominant inheritance rather than exclusively de novo occurrence.

◈

Mechanistic Hypotheses

PRR12 as a dosage-sensitive nuclear transcriptional cofactor

transcriptional_cofactor CANONICAL

Evidence balance 2 partial

The prevailing model: PRR12 is a nuclear, AT-hook-containing DNA-binding proline-rich protein acting as a transcriptional cofactor, and halving its dosage perturbs the developmental transcriptional programs of the brain, eye, heart, and kidney. It is the default explanation in every clinical report, but it is an inference from subcellular localization, expression pattern, domain prediction, and coexpression neighborhood rather than from demonstrated target genes or partner complexes; candidate interactors such as USP7, SOX2, and ESR2 have been nominated but are explicitly described by the delineating authors as experimentally unproven, and the primary literature continues to describe PRR12 as a gene of largely unknown function.

Pathograph links

PRR12 Haploinsufficiency -> Impaired Chromatin-Associated Transcriptional Regulation Reduced dosage of a nuclear DNA-binding cofactor lowers its contribution to developmental transcriptional programs.

Impaired Chromatin-Associated Transcriptional Regulation -> Disrupted Neural Development Perturbed developmental transcription in the fetal brain.

Impaired Chromatin-Associated Transcriptional Regulation -> Disrupted Ocular Morphogenesis Perturbed developmental transcription in the forming eye.

Impaired Chromatin-Associated Transcriptional Regulation -> Disrupted Cardiac Organogenesis Perturbed developmental transcription in the cardiac primordium.

Impaired Chromatin-Associated Transcriptional Regulation -> Disrupted Renal Organogenesis Perturbed developmental transcription in the developing kidney and ureteric bud.

Show evidence (2 references)

PMID:33314030 PARTIAL Human Clinical

"PRR12 encodes a Proline-Rich Protein 12 of unknown function. Current evidence suggests that PRR12 functions as a cofactor in transcriptional regulation within the nucleus"

States the hypothesis and simultaneously flags that the protein's function is unknown.

PMID:29556724 PARTIAL Human Clinical

"PRR12 encodes a proline-rich protein nuclear factor suspected to be involved in neural development."

A nuclear-factor role in neural development is suspected rather than demonstrated.

PRR12 as a NIPBL/cohesin cofactor and genome-integrity factor

cohesin_nipbl_axis EMERGING

Evidence balance 1 support 1 partial

A 2025 co-essentiality screen recast PRR12 as a cohesin-associated protein that binds the NIPBL/MAU2 loader, supports cohesin localization, and limits DNA double-strand break accumulation. If this is the operative mechanism in patients, PRR12-related neuroocular syndrome would belong mechanistically with the cohesinopathies such as NIPBL-related Cornelia de Lange syndrome, which would predict shared features (growth failure, developmental impairment, multisystem malformation) that the observed clinical picture is at least compatible with. The hypothesis has not been tested in patient cells or in a developmental context, and the authors themselves report that the requirement for PRR12 is cell-line dependent and weaker in the human line they tested. See the prr12_cohesin_human_relevance discussion.

Pathograph links

PRR12 Haploinsufficiency -> Impaired NIPBL-Cohesin Cooperation and Genomic Instability Reduced PRR12 impairs cohesin loading and the DNA damage response, an emerging alternative or additional route to the developmental phenotype.

Impaired NIPBL-Cohesin Cooperation and Genomic Instability -> Disrupted Neural Development Impaired cohesin function and accumulating DNA damage in neural progenitors as a candidate route to the neurodevelopmental phenotype.

Show evidence (2 references)

PMID:39742660 SUPPORT In Vitro

"by analyzing patterns of similar gene requirements across cell lines, we identify PRR12 as a mediator of cohesin and genome integrity"

The finding that generates this hypothesis.

PMID:39742660 PARTIAL In Vitro

"Together, our work identifies PRR12 as a regulator of cohesin and provides insight into how genome integrity is maintained across diverse cellular contexts."

The claim is framed as general cell biology, not as a disease mechanism, so it supports the hypothesis only partially.

Discussions and Knowledge Gaps

Why is the PRR12 ocular malformation present in only about half of affected individuals, and why is it so frequently unilateral with a structurally normal contralateral eye?

KNOWLEDGE GAP OPEN prr12_eye_penetrance

Attached to

pathophysiology#Disrupted Ocular Morphogenesis pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation

Incomplete and markedly asymmetric penetrance of a malformation caused by a constitutional heterozygous null allele is mechanistically informative. A uniformly deterministic dosage effect would predict bilateral, roughly symmetric disease. Unilaterality instead implies that ocular morphogenesis crosses a stochastic threshold independently in each optic vesicle, or that a somatic second hit, modifier locus, or transcriptional noise determines which eye is affected. No genotype-phenotype correlation explains it: the most N-terminal and the most C-terminal reported variants both produce eye disease, and cohort ascertainment route rather than allele position predicts the reported eye involvement rate. Resolving this bears directly on counseling, since a parent with an isolated unilateral eye anomaly may carry the same allele as a severely affected child.

Proposed experiments

Somatic and allele-specific analysis of discordant fellow eyes

prr12-eye-somatic-asymmetry

In individuals with unilateral disease from whom ocular tissue is available at surgery, compare somatic variant burden and allele-specific PRR12 expression between the malformed and the structurally normal eye to test whether a somatic second hit or skewed allelic expression explains the laterality.

Readouts

Difference in somatic variant burden and PRR12 allelic ratio between fellow eyes

pathophysiology#Disrupted Ocular Morphogenesis

Left-right concordance test in a bilateral eye-development model

prr12-eye-stochastic-threshold

Model PRR12 haploinsufficiency in a system that forms bilateral optic vesicles and score left-right concordance of the malformation against the concordance predicted by a stochastic-threshold model versus a deterministic dosage model.

Readouts

Left-right concordance rate of optic vesicle malformation

pathophysiology#Disrupted Ocular Morphogenesis

Modifier screen in PRR12 carriers stratified by eye involvement

prr12-eye-modifier-screen

Test for enrichment of rare and common variants in known MAC and anterior-segment-dysgenesis genes in PRR12 loss-of-function carriers, stratified by presence, severity, and laterality of eye involvement.

Readouts

Modifier allele burden by eye-involvement stratum

pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation

Does the PRR12-NIPBL/cohesin interaction and its DNA double-strand break phenotype, demonstrated principally in mouse NIH-3T3 cells, operate in the human developmental contexts that are affected in PRR12-related neuroocular syndrome?

HUMAN MODEL MISMATCH OPEN prr12_cohesin_human_relevance

Attached to

pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability

The cohesin finding is the first concrete molecular function assigned to PRR12 and would reclassify this disorder as a cohesinopathy adjacent to NIPBL-related Cornelia de Lange syndrome. But the evidence is explicitly context dependent: the authors report that human HeLa cells are less sensitive to PRR12 loss than mouse NIH-3T3 cells. Neither cell type is a neural progenitor, an optic vesicle cell, or a patient-derived line, and neither is heterozygous in the way patients are, since the experiments used complete loss rather than haploinsufficiency. Evidence for the mechanism therefore exists, but its translational validity to the human developmental phenotype is the open question, which is what distinguishes this from a plain absence of evidence. If the human requirement for PRR12 in cohesin loading is genuinely weak, the transcriptional-cofactor hypothesis remains the better explanation for the malformation pattern.

Proposed experiments

Cohesin and DNA damage phenotype in patient-derived human cells

prr12-cohesin-patient-cells

Test cohesin localization and double-strand break accumulation in PRR12 heterozygous patient-derived iPSCs and in iPSC-derived neural progenitors and retinal organoids, rather than in immortalized cell lines, and at heterozygous rather than null dosage.

Readouts

Cohesin chromatin occupancy and double-strand break burden in patient-derived neural and retinal cells

pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability

Direct comparison of PRR12 and NIPBL haploinsufficiency

prr12-vs-nipbl-comparison

Compare the transcriptomic and chromatin-architecture consequences of PRR12 haploinsufficiency with those of NIPBL haploinsufficiency in the same human cell type to test the cohesinopathy classification directly.

Readouts

Overlap of differentially expressed genes and altered chromatin contacts between PRR12 and NIPBL haploinsufficiency

pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability

Systematic re-phenotyping for Cornelia de Lange features

prr12-cdls-rephenotyping

Assess whether individuals with PRR12-related neuroocular syndrome show any Cornelia de Lange-associated features such as characteristic facies, limb reduction defects, hirsutism, or gastroesophageal reflux on systematic re-phenotyping, which would clinically corroborate the cohesinopathy hypothesis.

Readouts

Frequency of Cornelia de Lange-associated features in PRR12 carriers

pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability

What are the true population frequencies of eye involvement and cognitive impairment in PRR12 haploinsufficiency, once ascertainment bias is removed?

KNOWLEDGE GAP OPEN prr12_ascertainment_bias

Attached to

phenotypes#Developmental delay and impaired intellectual development phenotypes#Microphthalmia

The two principal cohorts disagree sharply in a way that is fully explained by how they were assembled. The neurodevelopmental matchmaking cohort reports developmental impairment in 100 percent and structural eye defects in 50 percent; the ophthalmic-genetics MAC and anterior-segment cohort reports eye defects in 100 percent, normal development and cognition in two of five, and no neuropsychiatric diagnoses at all. Both sets of figures are conditional on the ascertaining phenotype and neither is a population estimate. The curated frequency bands in this entry inherit that bias and should be revised when an unbiased series exists.

Proposed experiments

Ascertainment-neutral PRR12 variant cohort

prr12-unbiased-cohort

Assemble a PRR12 loss-of-function carrier cohort from unselected genome sequencing, such as a population biobank or newborn sequencing programme, rather than from phenotype-driven referral, and re-derive feature frequencies for eye involvement, cognition, and organ malformation.

Readouts

Ascertainment-neutral frequency of structural eye defect and of developmental impairment

phenotypes#Microphthalmia

Ophthalmological examination of first-degree relatives

prr12-relative-examination

Systematically examine all first-degree relatives of probands with slit lamp, dilated fundoscopy, and axial length measurement to detect mildly or unilaterally affected transmitting carriers who would otherwise be classified as unaffected.

Readouts

Proportion of clinically unaffected first-degree relatives with a detectable subclinical ocular anomaly

pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation

⚙

Pathophysiology

PRR12 Truncating Variant with Nonsense-Mediated Decay

Nearly all reported pathogenic PRR12 alleles are protein-truncating: frameshift, nonsense, and splice-site variants, plus whole-gene deletion and a balanced translocation that disrupts the locus. Because the premature termination codons fall well upstream of the final exon-exon junction, the mutant transcripts are predicted to be degraded by nonsense-mediated decay; if decay is escaped, the residual protein is severely truncated and functionally deficient. Either route removes one functional copy of the gene, so the operative lesion is allele loss rather than a dominant-negative or gain-of-function protein.

PRR12 hgnc:29217

Downstream

PRR12 Haploinsufficiency Loss of one functional allele halves the dose of PRR12 protein.

Show evidence (3 references)

PMID:33824499 SUPPORT Human Clinical

"We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12."

Documents the predominantly truncating variant spectrum, including a whole-gene deletion consistent with allele loss.

PMID:33314030 SUPPORT Human Clinical

"All variants reported thus far are predicted to result in protein truncation and are likely subject to nonsense mediated decay, thus haploinsufficiency represents the most likely disease mechanism."

States the nonsense-mediated-decay route from truncating allele to haploinsufficiency.

PMID:26163108 SUPPORT Human Clinical

"The resulting hybrid transcripts predict mRNA decay or, if translated, formation of truncated proteins, both due to frameshifts that introduced premature stop codons."

A structural rearrangement disrupting PRR12 converges on the same decay-or-truncation outcome, independent of point mutation.

PRR12 Haploinsufficiency

PRR12 is highly intolerant of loss-of-function variation in population databases, so a single inactivated allele is not buffered. The gene encodes a proline-rich nuclear protein with suspected DNA-binding activity whose expression in the fetal brain and visual system is consistent with a dosage-sensitive developmental role. Reduced predicted PRR12 expression is itself associated with eye and kidney phenotypes in a transcriptome-imputation (PrediXcan) analysis of electronic health record phecodes, providing human genetic support for dosage sensitivity that is independent of the rare-variant case series.

PRR12 as a dosage-sensitive nuclear transcriptional cofactor PRR12 as a NIPBL/cohesin cofactor and genome-integrity factor

PRR12 hgnc:29217

nucleus GO:0005634

Downstream

Impaired Chromatin-Associated Transcriptional Regulation Reduced dosage of a nuclear DNA-binding cofactor lowers its contribution to developmental transcriptional programs.

Impaired NIPBL-Cohesin Cooperation and Genomic Instability Reduced PRR12 impairs cohesin loading and the DNA damage response, an emerging alternative or additional route to the developmental phenotype.

Show evidence (4 references)

PMID:33824499 SUPPORT Human Clinical

"Predicted loss-of-function variants in this gene are extremely rare, indicating high intolerance of haploinsufficiency."

Population constraint data establish PRR12 as dosage sensitive.

PMID:33824499 SUPPORT Computational

"PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease."

Transcriptome-imputation analysis independently links reduced PRR12 dosage to eye and kidney phenotypes, matching the two organ systems most affected in the rare-variant cohort.

PMID:33824499 SUPPORT Human Clinical

"These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities."

The delineating study's conclusion that haploinsufficiency is the disease mechanism.

+ 1 more reference

Impaired Chromatin-Associated Transcriptional Regulation

PRR12 is a nuclear protein carrying two predicted AT-hook DNA-binding domains, with DNA-interacting domains that are highly conserved across vertebrates, and the prevailing model is that it functions as a cofactor in transcriptional regulation. Its coexpression neighborhood is enriched for chromatin regulators including SET-domain, bromodomain, zinc-finger, and BAH-domain proteins. Halving its dosage is proposed to perturb the transcriptional programs that pattern the developing forebrain and eye. The precise target genes, partner complexes, and DNA-binding specificity remain undefined, and PRR12 is still described in the primary literature as a gene of largely unknown function.

PRR12 as a dosage-sensitive nuclear transcriptional cofactor

regulation of DNA-templated transcription GO:0006355 ⚠ ABNORMAL

DNA binding GO:0003677 ↓ DECREASED chromatin binding GO:0003682 ↓ DECREASED

nucleus GO:0005634

Downstream

Disrupted Neural Development Perturbed developmental transcription in the fetal brain.

Disrupted Ocular Morphogenesis Perturbed developmental transcription in the forming eye.

Disrupted Cardiac Organogenesis Perturbed developmental transcription in the cardiac primordium.

Disrupted Renal Organogenesis Perturbed developmental transcription in the developing kidney and ureteric bud.

Show evidence (3 references)

PMID:33314030 PARTIAL Human Clinical

"PRR12 encodes a Proline-Rich Protein 12 of unknown function. Current evidence suggests that PRR12 functions as a cofactor in transcriptional regulation within the nucleus"

States the transcriptional-cofactor model while making explicit that the protein's function is otherwise unknown; marked PARTIAL because the model is inferred rather than experimentally demonstrated.

PMID:33824499 PARTIAL Human Clinical

"Proline Rich 12 (PRR12) is a gene of unknown function with suspected DNA-binding activity, expressed in developing mice and human brains."

DNA-binding activity is suspected rather than established, so this supports the node's premise only partially.

PMID:38674426 SUPPORT Model Organism

"In silico analysis reveals high evolutionary conservation in the DNA-interacting domains for both orthologs"

Deep conservation of the DNA-interacting domains in the zebrafish co-orthologs supports a conserved nucleic-acid-binding regulatory function.

Impaired NIPBL-Cohesin Cooperation and Genomic Instability

A co-essentiality screen identified PRR12 as a cohesin-associated factor. PRR12 physically interacts with the NIPBL/MAU2 cohesin loader and with the cohesin complex itself; its loss reduces cohesin localization and produces a substantial increase in DNA double-strand breaks, and PRR12 is recruited with NIPBL to sites of DNA damage in a NIPBL- and cohesin-dependent manner. Because NIPBL haploinsufficiency causes Cornelia de Lange syndrome, this places PRR12 adjacent to the cohesinopathies. Its curated explanatory scope here is deliberately limited to the neurodevelopmental arm, which is the only downstream edge this node asserts: impaired cohesin function and accumulating DNA damage in proliferating neural progenitors is a plausible route to developmental impairment, whereas no evidence connects this mechanism to the ocular, cardiac, or renal malformations, so those edges are not drawn. The evidence is cell-biological, comes principally from mouse NIH-3T3 cells, and has not yet been connected to patient tissue, so this is an emerging rather than an established disease mechanism.

PRR12 as a NIPBL/cohesin cofactor and genome-integrity factor

cohesin complex GO:0008278

sister chromatid cohesion GO:0007062 ↓ DECREASED double-strand break repair GO:0006302 ⚠ ABNORMAL

Downstream

Disrupted Neural Development Impaired cohesin function and accumulating DNA damage in neural progenitors as a candidate route to the neurodevelopmental phenotype.

Show evidence (3 references)

PMID:39742660 SUPPORT In Vitro

"We show that PRR12 interacts with NIPBL/MAU2 and the cohesin complex, and that the loss of PRR12 results in reduced cohesin localization and a substantial increase in DNA double-strand breaks in mouse NIH-3T3 cells."

Establishes the physical and functional link between PRR12, the NIPBL/MAU2 cohesin loader, and genome integrity.

PMID:39742660 SUPPORT In Vitro

"PRR12 co-localizes with NIPBL to sites of DNA damage in a NIPBL and cohesin-dependent manner."

Places PRR12 downstream of NIPBL and cohesin in the DNA damage response.

PMID:39742660 PARTIAL In Vitro

"We find that the requirement for PRR12 differs across cell lines, with human HeLa cells exhibiting reduced sensitivity to PRR12 loss compared with mouse NIH-3T3 cells, indicating context-specific roles."

The authors' own caveat that PRR12 dependence is context specific and weaker in the human cell line tested, which limits direct extrapolation to human disease.

Disrupted Neural Development

PRR12 is expressed in the nucleus of developing mouse and human brain, most strongly in fetal relative to adult brain, and in the zebrafish central nervous system from early development, with later expression in cerebellum, amygdala, and ventral telencephalon. Reduced dosage during forebrain development is the presumed substrate for the universal developmental impairment, the hypotonia, the microcephaly seen in a subset, and the neuropsychiatric features. Neural progenitor involvement is inferred from developmental expression rather than demonstrated in patient tissue.

neuron CL:0000540

nervous system development GO:0007399 ⚠ ABNORMAL

brain UBERON:0000955

Downstream

Neurodevelopmental Impairment Abnormal brain development manifests as developmental delay and intellectual disability.

Show evidence (2 references)

PMID:29556724 SUPPORT Human Clinical

"PRR12 encodes a proline-rich protein nuclear factor suspected to be involved in neural development. Its nuclear expression in fetal brains and in the vision system supports its role in brain and eye development more specifically."

Fetal brain expression links PRR12 dosage to neural development.

PMID:38674426 SUPPORT Model Organism

"prr12a is expressed early in zygotic development, mainly in the central nervous system, while prr12b expression initiates during gastrulation, localizing later to dopaminergic telencephalic and diencephalic cell clusters."

Zebrafish co-orthologs are expressed in the developing central nervous system, consistent with a conserved neurodevelopmental role.

Disrupted Ocular Morphogenesis

PRR12 is expressed in the developing visual system, and in zebrafish both co-orthologs are enriched in the ganglion cell and inner neural layers of the larval retina, with one also present in the ciliary marginal zone. Reduced PRR12 dosage during ocular morphogenesis produces a graded set of malformations: at the severe end failure of optic vesicle growth (anophthalmia and microphthalmia, in the most severe reported case with absent optic nerves, tracts, and chiasm), at the intermediate level failure of optic fissure closure (coloboma) and anterior segment dysgenesis (Peters anomaly, Rieger anomaly, stellate iris, microcornea), and at the mild end isolated iris, foveal, retinal, or optic nerve anomalies. A distinctive and unexplained feature is marked asymmetry: the malformation is frequently unilateral with a structurally normal contralateral eye, implying a stochastic or threshold-dependent rather than uniformly deterministic effect of the reduced dosage.

retinal ganglion cell CL:0000740

camera-type eye development GO:0043010 ⚠ ABNORMAL

eye UBERON:0000970

Downstream

MAC-Spectrum and Anterior Segment Eye Malformation Disrupted ocular morphogenesis produces the observed structural eye defects.

Show evidence (3 references)

PMID:33824499 SUPPORT Human Clinical

"Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."

Defines the structural ocular malformation spectrum and its incomplete penetrance in the delineating cohort.

PMID:33314030 SUPPORT Human Clinical

"Remarkably, ocular phenotypes were asymmetric in all individuals and unilateral (with structurally normal contralateral eye) in three."

Documents the characteristic asymmetry and unilaterality of the PRR12 eye malformation.

PMID:38674426 SUPPORT Model Organism

"Both transcripts are enriched in the ganglion cell and inner neural layers of the 72 hpf retina, with prr12b widely distributed in the ciliary marginal zone."

Retinal expression of the zebrafish co-orthologs supports a direct role for PRR12 in eye development.

Disrupted Cardiac Organogenesis

Congenital heart defects are the commonest extra-neural, extra-ocular malformation, affecting about half of reported individuals; the lesions described are septal defects and pulmonary stenosis, that is, defects of septation and outflow-tract formation rather than a single anatomical lesion. The developmental basis is not established. Unlike the renal arm, the cardiac arm has no independent supporting signal beyond the case series, so it rests solely on the inference of a dosage-sensitive developmental transcriptional program.

heart development GO:0007507 ⚠ ABNORMAL

heart UBERON:0000948

Downstream

Congenital Heart Malformation Disrupted cardiac organogenesis manifests as structural heart defects.

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Quantifies cardiac malformation in the delineating cohort.

Disrupted Renal Organogenesis

Kidney and urinary tract anomalies affect about a third of reported individuals, with hydronephrosis, duplicated ureter, and vesicoureteral reflux reported - a collecting-system and ureteric-bud pattern rather than a parenchymal one. The renal arm is distinguished from the cardiac arm by having independent human genetic corroboration: renal phecodes were enriched among the phenotypes associated with reduced predicted PRR12 expression in a transcriptome-imputation analysis, so two orthogonal lines of human evidence converge on the kidney.

kidney development GO:0001822 ⚠ ABNORMAL

kidney UBERON:0002113

Downstream

Kidney and Urinary Tract Malformation Disrupted renal organogenesis manifests as structural kidney and urinary tract defects.

Show evidence (2 references)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Quantifies renal malformation in the delineating cohort.

PMID:33824499 SUPPORT Computational

Transcriptome-imputation independently implicates the kidney as a dosage-sensitive PRR12 target organ; this snippet is renal- and ocular-specific and does not speak to the heart, which is why it is attached here rather than to the cardiac node.

Neurodevelopmental Impairment

The clinical endpoint of the neural arm: developmental delay or impaired intellectual development, present in every individual in the delineating cohort, together with hypotonia and neuropsychiatric comorbidity. Severity ranges from mild learning difficulty to non-verbal cognitive impairment requiring full assistance, and a minority of individuals ascertained through ophthalmology have entirely normal development. The congenital malformations are static, but developmental capabilities may improve with maturation and intervention; no prospective natural-history data exist.

Show evidence (2 references)

PMID:33824499 SUPPORT Human Clinical

"All patients had developmental impairment."

Developmental impairment is the one universal finding in the delineating cohort.

PMID:33314030 PARTIAL Human Clinical

"Additional phenotypic expansions included short stature and normal development/cognition, each noted in two individuals in this cohort, as well as absence of neuropsychiatric disorders in all."

Refines rather than contradicts the universality claim - in an ophthalmology-ascertained cohort some individuals have normal cognition, so developmental impairment is not obligate.

MAC-Spectrum and Anterior Segment Eye Malformation

The clinical endpoint of the ocular arm: anophthalmia, microphthalmia, coloboma, Peters anomaly, stellate iris pattern, cataract, foveal hypoplasia, glaucoma, persistent fetal vasculature, and optic nerve anomalies, in variable and frequently asymmetric combinations. In ophthalmology-ascertained families the eye phenotype may be entirely isolated with no systemic features.

eye UBERON:0000970

Show evidence (2 references)

PMID:33314030 SUPPORT Human Clinical

"The ocular phenotypes in our cohort were more severe than previously reported, with microphthalmia (4) or coloboma (1) seen in all five individuals, Peters anomaly in three, and cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each."

Enumerates the range of structural ocular findings attributable to PRR12 loss of function.

PMID:33314030 SUPPORT Human Clinical

"The ocular phenotypes were isolated with no additional systemic features observed in two unrelated families."

Documents that the eye malformation can occur as a nonsyndromic phenotype.

Congenital Heart Malformation

The clinical endpoint of the cardiac arm: structural congenital heart disease, present in about half of reported individuals and requiring echocardiographic screening at diagnosis. Atrial septal defect, ventricular septal defect, and pulmonary stenosis are the reported lesions; those specific types are from the delineating study's full text and are not abstract-verifiable.

heart UBERON:0000948

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Establishes congenital heart malformation as a recurrent clinical endpoint.

Kidney and Urinary Tract Malformation

The clinical endpoint of the renal arm: structural kidney and urinary tract anomalies, present in about a third of reported individuals and requiring renal ultrasound at diagnosis. Hydronephrosis, duplicated ureter, and vesicoureteral reflux are the reported lesions; those specific types are from the delineating study's full text and are not abstract-verifiable.

kidney UBERON:0002113

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Establishes kidney and urinary tract malformation as a recurrent clinical endpoint.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Cardiovascular 1

Congenital heart defect FREQUENT Abnormal heart morphology HP:0001627

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Heart defects in 52 percent of the cohort maps to the FREQUENT band.

Eye 8

Microphthalmia FREQUENT Microphthalmia HP:0000568

Show evidence (2 references)

PMID:33314030 SUPPORT Human Clinical

Microphthalmia in 4 of 5 individuals in the ophthalmic-genetics cohort.

PMID:33824499 SUPPORT Human Clinical

"Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."

Structural eye defects including microphthalmia in 50 percent of the delineating cohort, supporting the FREQUENT band for the ocular phenotype overall.

Coloboma Coloboma HP:0000589

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."

Coloboma is part of the reported structural eye defect spectrum.

Peters anomaly Peters anomaly HP:0000659

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

Peters anomaly is an ascertaining phenotype for PRR12 loss-of-function alleles.

Cataract Cataract HP:0000518

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

"cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each"

Cataract reported in one individual of the ophthalmic cohort.

Glaucoma Glaucoma HP:0000501

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

"Individual 3 was diagnosed with bilateral Peters anomaly, left microphthalmia and right glaucoma"

Glaucoma documented in an individual with bilateral Peters anomaly.

Nystagmus Nystagmus HP:0000639

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

"the daughter also has Peters anomaly in the affected eye, bilateral nystagmus, and mild developmental delay/learning difficulties"

Bilateral nystagmus documented in an individual with a transmitted PRR12 splice variant.

Strabismus Strabismus HP:0000486

Show evidence (2 references)

PMID:33314030 SUPPORT Human Clinical

"this individual was similarly affected with intellectual disability, anxiety/autistic like features, and myopia with strabismus, but had normal irises"

Strabismus documented in an individual with PRR12 disruption by translocation.

PMID:33314030 SUPPORT Human Clinical

"iris coloboma was present in two of the three, a stellate iris pattern was reported in all three, and myopia and exotropia were also seen"

Exotropia, a form of strabismus, in the founding three-patient series.

Visual impairment Visual impairment HP:0000505

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."

The founding series documents vision abnormalities, as distinct from structural eye abnormalities, in all three individuals.

Genitourinary 1

Kidney anomaly FREQUENT Abnormality of the kidney HP:0000077

Show evidence (2 references)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Kidney anomalies in 35 percent of the cohort maps to the FREQUENT band.

PMID:33824499 SUPPORT Computational

Independent transcriptome-imputation support for renal involvement.

Head and Neck 2

Microcephaly Microcephaly HP:0000252

Show evidence (1 reference)

PMID:33824499 PARTIAL Human Clinical

"These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities."

Microcephaly is documented in the full text of the delineating cohort and in the derived OMIM and MONDO definitions, but the abstract quantifies only hypotonia, heart, growth, and kidney features; this evidence item therefore supports the disorder framing only partially and the specific microcephaly claim is not abstract-verifiable.

Abnormal facial shape Abnormal facial shape HP:0001999

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."

Dysmorphic features in 3 of 3 of the founding series.

Musculoskeletal 2

Generalized hypotonia FREQUENT Generalized hypotonia HP:0001290

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Hypotonia in 61 percent of the cohort maps to the FREQUENT band, 30 to 79 percent.

Scoliosis Scoliosis HP:0002650

Show evidence (2 references)

PMID:38798311 SUPPORT Human Clinical

"He was the first PRR12 deficiency patient in China and presented with ID, short stature, and mild scoliosis."

Mild scoliosis reported in an independent case.

PMID:29556724 PARTIAL Human Clinical

"Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."

Skeletal abnormalities are reported generically, without scoliosis being named, so this supports the claim only partially.

Nervous System 6

Developmental delay and impaired intellectual development VERY_FREQUENT Global developmental delay HP:0001263

Show evidence (2 references)

PMID:33824499 SUPPORT Human Clinical

"All patients had developmental impairment."

24 of 24 individuals affected, supporting the VERY_FREQUENT band.

PMID:29556724 SUPPORT Human Clinical

"All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."

All three individuals in the founding series had global developmental delay.

Intellectual disability VERY_FREQUENT Intellectual disability HP:0001249

Show evidence (2 references)

PMID:29556724 SUPPORT Human Clinical

"All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."

Intellectual disability in 3 of 3 of the founding series, and it is the presenting feature in the translocation and single-case reports.

PMID:38798311 SUPPORT Human Clinical

"He was the first PRR12 deficiency patient in China and presented with ID, short stature, and mild scoliosis."

Intellectual disability was the presenting feature in an independent single-case report.

Autism spectrum behavior Autism HP:0000717

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."

Autistic behavior is a reported variable feature in the founding series.

Anxiety Anxiety HP:0000739

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."

Anxiety is a reported variable behavioral feature.

Attention deficit hyperactivity disorder Attention deficit hyperactivity disorder HP:0007018

Show evidence (1 reference)

PMID:38798311 SUPPORT Human Clinical

"He could not concentrate on his studies and was diagnosed with attention deficit hyperactivity disorder (ADHD)."

Formal ADHD diagnosis in a reported individual.

Sleep disturbance Sleep disturbance HP:0002360

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."

Sleeping problems are a reported variable feature of the founding series.

Growth 2

Growth failure FREQUENT Failure to thrive HP:0001508

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Growth failure in 54 percent of the cohort maps to the FREQUENT band.

Short stature OCCASIONAL Short stature HP:0004322

Show evidence (2 references)

PMID:33314030 SUPPORT Human Clinical

"Additional phenotypic expansions included short stature and normal development/cognition, each noted in two individuals in this cohort, as well as absence of neuropsychiatric disorders in all."

Short stature in 2 of 5 individuals, newly recognized as part of the PRR12 phenotype; reported conservatively as OCCASIONAL because it is not a documented feature of the larger neurodevelopmentally ascertained series.

PMID:38798311 SUPPORT Human Clinical

"The insulin-like growth factor 1 (IGH-1) was low in our patient, which may be the cause of his short stature."

Independent case with short stature and a candidate endocrine mechanism.

Other 5

Anophthalmia Anophthalmia HP:0000528

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."

Anophthalmia is explicitly listed within the structural eye defect spectrum.

Iris coloboma Iris coloboma HP:0000612

Show evidence (2 references)

PMID:29556724 SUPPORT Human Clinical

"Eye abnormalities were consistent among the three patients and consisted of stellate iris pattern and iris coloboma."

Iris coloboma was one of the two consistent ocular findings in the founding series.

PMID:33314030 SUPPORT Human Clinical

"Individual 2 displays a significant ocular phenotype with bilateral iris coloboma, foveal hypoplasia, and nystagmus"

Bilateral iris coloboma in an individual with an otherwise isolated ocular phenotype.

Stellate iris pattern Abnormality iris morphology HP:0000525

Show evidence (1 reference)

PMID:29556724 SUPPORT Human Clinical

"Eye abnormalities were consistent among the three patients and consisted of stellate iris pattern and iris coloboma."

Stellate iris pattern in 3 of 3 of the founding series.

Abnormal optic nerve morphology Abnormal optic nerve morphology HP:0000587

Show evidence (1 reference)

PMID:33824499 SUPPORT Human Clinical

"Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."

Optic nerve abnormalities are explicitly enumerated in the structural eye defect spectrum.

Foveal hypoplasia Hypoplasia of the fovea HP:0007750

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

"Individual 2 displays a significant ocular phenotype with bilateral iris coloboma, foveal hypoplasia, and nystagmus"

Foveal hypoplasia in an individual with an otherwise isolated ocular phenotype.

🧬

Genetic Associations

PRR12 (Heterozygous loss-of-function variant, usually de novo)

Gene: PRR12 hgnc:29217 relationship_type: CAUSATIVE

Show evidence (5 references)

PMID:33824499 SUPPORT Human Clinical

"We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12."

Defines the pathogenic allelic spectrum in the largest reported cohort.

PMID:33824499 SUPPORT Human Clinical

"Three individuals had additional genetic findings, possibly confounding the phenotype."

Documents that co-occurring genetic diagnoses complicate genotype-phenotype attribution in this disorder.

PMID:41357555 SUPPORT Human Clinical

"A co-occurring de novo PRR12 c.768del (p.Ala257Leufs*58) frameshift mutation explained his developmental delay."

A worked example of dual molecular diagnosis in which the PRR12 frameshift accounts specifically for the neurodevelopmental component.

+ 2 more references

💊

Medical Actions

Physical Therapy

Action: physical therapy Ontology label: Physical Therapy NCIT:C15302

There is no disease-modifying therapy, gene therapy, RNA therapy, or PRR12-targeted treatment for this disorder, and no interventional trial has been registered. Management is supportive and multidisciplinary. Physical therapy addresses the hypotonia and the motor component of the developmental delay.

Mechanism Target:

MODULATES Neurodevelopmental Impairment — Symptomatic support that may improve motor function without addressing the underlying haploinsufficiency.

Target Phenotypes: Generalized hypotonia HP:0001290

Show evidence (1 reference)

PMID:33824499 PARTIAL Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

Hypotonia in 61 percent of the cohort establishes the indication for physical therapy; the cohort study does not itself evaluate any intervention, so this is indirect support only.

Occupational Therapy

Action: occupational therapy Ontology label: Occupational Therapy NCIT:C121351

Occupational therapy supports adaptive and daily-living skills. It is particularly relevant in this disorder because the combination of developmental impairment with visual impairment compounds functional disability, and because severity ranges up to full dependence for activities of daily living.

Mechanism Target:

MODULATES Neurodevelopmental Impairment — Symptomatic support for adaptive function; does not address the underlying haploinsufficiency.

Show evidence (1 reference)

PMID:33824499 PARTIAL Human Clinical

"All patients had developmental impairment."

Universal developmental impairment establishes the indication; the cohort study evaluates no intervention, so support is indirect.

Speech and Language Therapy

Action: speech and language therapy Ontology label: Speech Language Therapy NCIT:C159273

Speech and language therapy addresses the expressive language deficit. This is a distinct need rather than a generic add-on: a subset of individuals in the delineating cohort had isolated speech-language delay as their only developmental impairment, and at the severe end individuals are non-verbal.

Mechanism Target:

MODULATES Neurodevelopmental Impairment — Symptomatic support for communication; does not address the underlying haploinsufficiency.

Show evidence (1 reference)

PMID:33824499 PARTIAL Human Clinical

"All patients had developmental impairment."

Universal developmental impairment, which per the full text includes isolated speech-language delay in a subset, establishes the indication; the cohort study evaluates no intervention.

Ophthalmic Surgical Management

Action: ophthalmologic surgical procedure Ontology label: Ophthalmologic Surgical Procedure NCIT:C15331

Surgical management of the structural ocular malformation: strabismus surgery, corneal or cataract surgery where indicated for Peters anomaly or lens opacity, glaucoma surgery or intraocular pressure control, and prosthetic or socket care for anophthalmia and severe microphthalmia. No intervention restores the developmental malformation itself. Because the disease is characteristically asymmetric, surgical planning must protect the function of the better-seeing eye.

Mechanism Target:

MODULATES MAC-Spectrum and Anterior Segment Eye Malformation — Addresses the consequences of the structural eye malformation rather than the morphogenetic defect.

Target Phenotypes: Peters anomaly HP:0000659 Cataract HP:0000518 Glaucoma HP:0000501 Strabismus HP:0000486

Show evidence (1 reference)

PMID:33314030 PARTIAL Human Clinical

The enumerated surgically and optically manageable lesions establish the indication; the report does not evaluate treatment outcomes, so support is indirect.

Low Vision Rehabilitation and Refractive Management

Action: rehabilitation Ontology label: Rehabilitation NCIT:C15315

Non-surgical visual management, split out from the surgical entry because it is a rehabilitative rather than an operative modality: low-vision services and aids, refractive correction, and amblyopia therapy. Amblyopia therapy is especially important in this disorder because the malformation is frequently unilateral, so the structurally normal fellow eye is at risk of deprivation amblyopia if the affected eye is simply written off.

Target Phenotypes: Visual impairment HP:0000505

Show evidence (1 reference)

PMID:29556724 PARTIAL Human Clinical

"All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."

Vision abnormalities in all three individuals of the founding series establish the indication for visual rehabilitation; no study evaluates the intervention, so support is indirect.

Cardiac and Renal Surveillance and Supportive Care

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Standard cardiology management of septal defects and pulmonary stenosis, and nephrology or urology management of hydronephrosis, vesicoureteral reflux, and duplicated collecting systems, alongside nutritional and feeding support for the growth failure. No disorder-specific surveillance guideline exists; care follows the general standards for each individual malformation.

Mechanism Target:

MODULATES Congenital Heart Malformation — Manages the cardiac malformation endpoint; does not alter the developmental cause.

MODULATES Kidney and Urinary Tract Malformation — Manages the renal malformation endpoint; does not alter the developmental cause.

Show evidence (1 reference)

PMID:33824499 PARTIAL Human Clinical

"Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."

The frequency of cardiac, renal, and growth involvement establishes the indication for surveillance and supportive care; the cohort study evaluates no intervention.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counseling should cover the autosomal dominant mechanism, the predominantly de novo origin with correspondingly low but non-zero recurrence risk from parental germline mosaicism, the theoretical 50 percent transmission risk for an affected individual, the documented instance of parent-to-child transmission, and the wide and currently unpredictable phenotypic variability, including the possibility of an affected relative with isolated unilateral eye disease and normal cognition. Reproductive options after molecular diagnosis include prenatal diagnosis and preimplantation genetic testing.

Show evidence (1 reference)

PMID:33314030 SUPPORT Human Clinical

"Given the variability observed in reported individuals thus far, it seems likely that additional phenotypic variation will be identified as more PRR12 variants are discovered."

The authors' explicit statement of unresolved phenotypic variability is what counseling must convey.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from PRR12-Related Neuroocular Syndrome:

SOX2-related anophthalmia/microphthalmia syndrome Not Yet Curated MONDO:0008799

Overlapping Features SOX2 is the single commonest cause of syndromic anophthalmia and microphthalmia and shares the core PRR12 combination of a severe MAC-spectrum eye malformation with developmental delay. Both genes appear side by side in the diagnostic yield of the same anophthalmia/microphthalmia sequencing cohorts, and both have been reported to produce unilateral ocular anomalies, so SOX2 is the first alternative to exclude.

Distinguishing Features

Oesophageal atresia and tracheo-oesophageal fistula are characteristic of the SOX2 syndrome and are not features of PRR12-related disease.
Hypogonadotropic hypogonadism and genital anomalies point to SOX2 rather than PRR12.
PRR12-related eye disease is characteristically asymmetric or unilateral, whereas SOX2 anophthalmia is more often bilateral and more uniformly severe.
Congenital heart and kidney defects are prominent in PRR12-related disease and are not part of the SOX2 core pattern.

Show evidence (2 references)

PMID:41953648 SUPPORT Human Clinical

"The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."

SOX2 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort, establishing them as members of one differential.

PMID:33314030 SUPPORT Human Clinical

"While genes such as SOX2 and OTX2 have been occasionally reported to cause unilateral ocular anomalies"

Places SOX2 and OTX2 alongside PRR12 as the genes capable of producing unilateral developmental ocular anomalies, which is the specific diagnostic scenario in which PRR12 is easily missed.

OTX2-related syndromic microphthalmia Not Yet Curated MONDO:0012413

Overlapping Features OTX2 haploinsufficiency causes a dominant, largely de novo MAC-spectrum disorder with optic nerve involvement and developmental delay, closely mirroring the PRR12 presentation. As with SOX2, OTX2 is recovered from the same diagnostic cohorts and can produce unilateral disease.

Distinguishing Features

Pituitary hormone deficiency, including combined pituitary hormone deficiency, is a recognized OTX2 feature and has not been reported as part of the PRR12 phenotype.
Retinal dystrophy with an abnormal electroretinogram is more characteristic of OTX2 than of PRR12.
Anterior segment dysgenesis with Peters anomaly and a stellate iris pattern favours PRR12.
Congenital heart and kidney malformations are common in PRR12-related disease and are not core OTX2 features.

Show evidence (2 references)

PMID:41953648 SUPPORT Human Clinical

"The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."

OTX2 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort.

PMID:33314030 SUPPORT Human Clinical

"While genes such as SOX2 and OTX2 have been occasionally reported to cause unilateral ocular anomalies"

OTX2 shares with PRR12 the capacity to cause unilateral ocular anomalies.

CHARGE syndrome and the wider CHD7 disorder spectrum MONDO:0008965

Overlapping Features The most important syndromic differential, because CHARGE syndrome reproduces almost the entire PRR12 multisystem pattern, namely coloboma, heart defect, growth and developmental delay, and renal anomalies. Both are dominant, typically de novo, chromatin-associated disorders, since CHD7 is a chromatin remodeller and PRR12 a chromatin-associated nuclear protein, so the mechanistic as well as the clinical overlap is real. CHD7 also appears with PRR12 in the same MAC diagnostic cohorts.

Distinguishing Features

Choanal atresia is a cardinal CHARGE feature and is not reported in PRR12-related disease.
Semicircular canal hypoplasia and cranial nerve anomalies, including anosmia and facial palsy, are highly discriminating for CHD7.
Characteristic external ear anomalies with deafness point to CHARGE.
Genital hypoplasia and hypogonadotropic hypogonadism favour CHARGE.
Anterior segment dysgenesis with Peters anomaly favours PRR12, whereas the CHARGE ocular lesion is characteristically a chorioretinal or optic nerve coloboma.

Show evidence (3 references)

PMID:20301296 SUPPORT Human Clinical

"The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness)."

GeneReviews enumerates the CHARGE cardinal features, showing both the overlap with PRR12 in coloboma, heart defect, and growth and developmental delay, and the discriminators of choanal atresia, genital hypoplasia, and ear anomalies.

PMID:20301296 SUPPORT Human Clinical

"the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies"

The expanded CHD7 spectrum includes renal anomalies, completing the eye, heart, and kidney overlap with PRR12 and making cranial nerve and vestibular assessment the practical discriminator.

PMID:41953648 SUPPORT Human Clinical

"The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."

CHD7 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort.

PAX2-related disorder, formerly renal coloboma syndrome Not Yet Curated MONDO:0007352

Overlapping Features A dominant disorder pairing renal anomalies with optic nerve anomalies, precisely the eye-plus-kidney combination that PRR12 produces, and therefore a natural differential when a child presents with coloboma and a structural renal anomaly. It offers an unusually clean discriminator.

Distinguishing Features

Iris coloboma has not been reported in PAX2-related disorder, so an iris coloboma argues against it and towards PRR12.
The PAX2 ocular lesion is specifically optic nerve coloboma or dysplasia, not the globe-size and anterior-segment defects seen with PRR12.
Renal involvement in PAX2-related disorder is near-obligate and progresses to renal insufficiency or end-stage renal disease, whereas PRR12 renal anomalies affect a minority and are structural rather than progressive.
Congenital heart defects and significant developmental delay are not core PAX2 features but are common in PRR12-related disease.

Show evidence (2 references)

PMID:20301624 SUPPORT Human Clinical

"Iris colobomas have not been reported in any individual with PAX2–related disorder."

GeneReviews provides a near-absolute discriminator, since iris coloboma is a recurrent PRR12 finding and argues against PAX2-related disorder.

PMID:20301624 SUPPORT Human Clinical

"Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals."

The near-obligate renal involvement in PAX2-related disorder contrasts with the roughly one-third rate in PRR12-related disease, so a child with severe progressive renal disease plus optic nerve coloboma is more likely to have PAX2-related disorder.

SALL4-related disorders, including acro-renal-ocular syndrome MONDO:0011812

Overlapping Features The acro-renal-ocular phenotype within the SALL4 spectrum combines ocular coloboma, renal anomalies, and cardiac malformation, overlapping the PRR12 eye-heart-kidney triad, and the associated eye movement disorder can be mistaken for the strabismus seen in PRR12-related disease. The renal lesions overlap closely, including vesicoureteral reflux, which is also reported in PRR12-related disease.

Distinguishing Features

Radial ray malformation, meaning thumb hypoplasia or aplasia, triphalangeal or duplicated thumb, and radial hypoplasia, is the defining SALL4 feature and is absent in PRR12-related disease.
Duane anomaly, a congenital cranial dysinnervation disorder with globe retraction on adduction, is distinct from the common comitant strabismus of PRR12-related disease.
Anterior segment dysgenesis with Peters anomaly and microphthalmia favours PRR12, whereas the SALL4 ocular lesion is characteristically a coloboma.
Significant intellectual disability is typical of PRR12-related disease and is not a core SALL4 feature.

Show evidence (2 references)

PMID:20301547 SUPPORT Human Clinical

"AROS is characterized by radial ray malformations, renal abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, vesicoureteral reflux, bladder diverticula), ocular coloboma, and Duane anomaly."

The acro-renal-ocular phenotype overlaps PRR12 on coloboma and renal anomaly including vesicoureteral reflux, while the radial ray malformation supplies the discriminator.

PMID:20301547 SUPPORT Human Clinical

"DRRS is characterized by uni- or bilateral Duane anomaly and radial ray malformation that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs"

Confirms that limb involvement is the defining SALL4 feature, which examination of the thumbs and forearms will resolve.

PAX6 aniridia syndrome and the wider PAX6-related spectrum Not Yet Curated MONDO:0007119

Overlapping Features Phenotypically the closest ocular mimic of PRR12-related disease, and arguably the most instructive differential in this entry, because PAX6 reproduces nearly the whole curated PRR12 feature list, including foveal hypoplasia, glaucoma, cataract, optic nerve coloboma and hypoplasia, nystagmus, and microphthalmia, together with developmental delay or intellectual disability, autism, ADHD, anxiety, and disordered sleep. The MONDO binding used here is the aniridia term, but the intended comparator is the wider PAX6-related spectrum, which includes non-aniridic anterior segment phenotypes.

Distinguishing Features

Partial or complete iris hypoplasia, that is aniridia, and corneal keratopathy with limbal stem cell failure are PAX6 hallmarks not seen in PRR12-related disease.
Interocular symmetry is the sharpest discriminator, because PAX6 disease is usually near-symmetric between the two eyes whereas PRR12 disease is asymmetric in essentially all reported individuals and frequently unilateral.
A stellate iris pattern with iris coloboma favours PRR12 over the iris hypoplasia of PAX6.
Congenital heart defects and kidney anomalies are part of the PRR12 phenotype and are not features of PAX6 aniridia syndrome; a WT1 deletion causing WAGR syndrome should instead be considered when aniridia occurs with renal disease.

Show evidence (3 references)

PMID:20301534 SUPPORT Human Clinical

"Classic aniridia affects the iris (partial or full iris hypoplasia), cornea (corneal keratopathy), anterior segment (resulting in raised intraocular pressure and glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia)."

The PAX6 ocular feature list overlaps the curated PRR12 ocular phenotypes almost item for item, which is why iris hypoplasia and corneal keratopathy must be sought as discriminators.

PMID:20301534 SUPPORT Human Clinical

"Although the severity of aniridia shows interfamilial and intrafamilial variability, little variability is usually observed in the two eyes of an affected individual."

Provides the sharpest discriminator against PRR12, whose defining ocular feature is marked asymmetry between the two eyes, often with one structurally normal eye.

PMID:20301534 SUPPORT Human Clinical

"developmental delay / intellectual disability; neurobehavioral/psychiatric manifestations such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and behavioral dysregulation; and mood disorders such as depression and anxiety"

The PAX6 neurodevelopmental and neuropsychiatric profile matches the PRR12 profile closely, so the neurobehavioural phenotype cannot be used to separate the two and discrimination must rest on ocular and visceral features.

{ }

Source YAML

click to show

name: PRR12-Related Neuroocular Syndrome
creation_date: "2026-08-01T12:00:00Z"
description: >-
  PRR12-related neuroocular syndrome (neuroocular syndrome 1, NOC1) is a rare
  autosomal dominant neurodevelopmental disorder caused by heterozygous
  loss-of-function variants in PRR12, which encodes a proline-rich,
  chromatin-associated nuclear protein expressed in the developing brain and
  visual system. Developmental impairment is the one near-constant finding;
  the ocular phenotype is strikingly variable, spanning the
  anophthalmia-microphthalmia-coloboma (MAC) spectrum together with anterior
  segment dysgenesis (Peters anomaly, stellate iris pattern, iris coloboma)
  and optic nerve anomalies, and is present in only about half of reported
  individuals. Additional common features are hypotonia, congenital heart
  defects, growth failure or short stature, kidney anomalies, microcephaly,
  dysmorphic features, and neuropsychiatric problems including autism, ADHD,
  and anxiety. The disorder was delineated only in 2018-2021 and fewer than
  forty individuals have been reported, so the phenotypic boundaries are
  still being defined.
category: Mendelian
parents:
- hereditary disease
- syndromic microphthalmia
synonyms:
- neuroocular syndrome 1
- NOC1
- PRR12 haploinsufficiency
- PRR12-related disorder
- multiple congenital anomalies-neurodevelopmental delay-ocular abnormalities syndrome
disease_term:
  preferred_term: PRR12-related neuroocular syndrome
  term:
    id: MONDO:0971007
    label: neuroocular syndrome 1
notes: >-
  Naming. MONDO and OMIM 619539 label this entity "neuroocular syndrome 1" as
  part of a numbered series under the MONDO grouping "neuroocular syndrome"
  MONDO:0859193. This entry uses the gene-anchored clinical name
  "PRR12-related neuroocular syndrome" for three reasons. First, it matches
  the way the primary literature refers to the condition, which is
  consistently gene-first. Second, the bare phrase "neuroocular syndrome" is
  ambiguous in PubMed: the overwhelming majority of indexed hits for it are
  spaceflight-associated neuro-ocular syndrome, a mechanistically unrelated
  microgravity disorder already curated separately in dismech as
  "Spaceflight Associated Neuro-Ocular Syndrome". Third, numbered disease
  series are a documented named-entity-confusion risk for automated curation.
  The MONDO binding is unchanged, so the identifier remains authoritative
  while the display name is unambiguous. This follows the gene-anchored
  convention already used by the sibling entries
  "RARB-related syndromic microphthalmia" and
  "STRA6-related syndromic microphthalmia".

  Scope relative to other MAC entries. PRR12 is one of more than 100 genes in
  the microphthalmia/anophthalmia/coloboma and anterior-segment-dysgenesis
  spectrum. This entry covers the PRR12-specific syndromic disorder. The
  gene-agnostic isolated form is curated separately as
  "Isolated Anophthalmia-Microphthalmia Syndrome" MONDO:0016764, and the
  SOX2, OTX2, RAX, and STRA6 forms are distinct entities; those genes are not
  implicated in this disorder and were explicitly excluded during the
  named-entity-confusion preflight.

  No GeneReviews chapter exists for PRR12 or for neuroocular syndrome 1; a
  PubMed search for "PRR12 GeneReviews" returned no results on 2026-08-01, so
  no GeneReviews phenotype baseline was available.

  Full-text-only findings. The Edison/falcon deep-research run for this entry
  performed a full-text read of the delineating cohort study, PMID:33824499,
  whose PubMed record is abstract-only. Several clinically useful figures
  therefore appear in the report but cannot be snippet-verified against the
  cached abstract and are recorded here as prose rather than as evidence
  items, per the project SOP. From that full text: developmental impairment
  comprised global developmental delay in 17, isolated motor delay in 3, and
  isolated speech-language delay in 4; intellectual disability was present in
  all 11 individuals older than seven years; coloboma occurred in 7 of 24
  (iris most often, but also optic nerve, macula, chorioretina, and lens);
  anophthalmia or microphthalmia in 4 of 24; visual impairment in 17 of 22
  assessed; strabismus in 8 of 22; microcephaly in 7 of 24; cryptorchidism in
  5 of 13 males; cleft palate in 4 of 24; intestinal malrotation in 2 of 24.
  The 12 cardiac defects comprised six atrial septal defects, two ventricular
  septal defects, and three pulmonary stenoses. Renal findings included
  hydronephrosis, duplicated ureter, and vesicoureteral reflux. Facial
  features (wide-set eyes, epicanthal folds, low-set ears, upturned nasal
  tip, thin vermilion) each occurred in at least a quarter of individuals but
  the authors found no recognizable gestalt. Constraint metrics were pLI
  1.00, observed/expected loss-of-function 0.0, and LOEUF 0.051. The protein
  contains two predicted AT-hook DNA-binding domains, and candidate
  interactors USP7, SOX2, and ESR2 were nominated but explicitly described
  as experimentally unproven. Ages spanned 5 months to 36 years.

  Ascertainment bias is a live caveat. The largest cohort was assembled
  through neurodevelopmental matchmaking platforms (PMID:33824499) while the
  deepest ocular phenotyping comes from an ophthalmic-genetics MAC and
  anterior-segment-dysgenesis cohort (PMID:33314030). The two routes report
  very different rates of both eye involvement and cognitive impairment, so
  the curated feature frequencies should be read as cohort-conditional
  rather than population estimates. See the prr12_ascertainment_bias
  discussion.
inheritance:
- name: Autosomal dominant inheritance
  description: >-
    Disease results from a single heterozygous loss-of-function PRR12 allele.
    Most reported variants arose de novo, but the first dominantly
    transmitted allele, a splice-site variant segregating from an affected
    mother to her affected daughter, confirms germline transmission, and
    somatic mosaicism has been documented in at least one individual.
    Recurrence risk for unaffected parents of a de novo case is low but not
    zero because parental germline mosaicism cannot be excluded.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report on three unrelated patients with heterozygous de novo apparent loss-of-function mutations in PRR12 detected by clinical whole exome sequencing"
    explanation: The founding series establishes heterozygous de novo PRR12 variants as the disease mechanism, that is, dominant inheritance.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified four novel pathogenic loss-of-function alleles in PRR12 in families affected by complex microphthalmia and/or Peters anomaly, including two de novo, the first dominantly transmitted allele, as well as the first splicing variant."
    explanation: Documents the first parent-to-child transmitted PRR12 allele, confirming autosomal dominant inheritance rather than exclusively de novo occurrence.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Fewer than forty individuals have been reported since the disorder was
    delineated. The largest series brought the published total to 24
    individuals; a separate ophthalmic-genetics cohort added five more, and
    subsequent single-case reports from China, the United States, and Egypt
    have added a handful. No population-based prevalence estimate, incidence
    figure, founder effect, or ethnic enrichment has been described.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We add 21 individuals with similar PRR12 variants identified via matchmaking platforms, bringing the total number to 24."
    explanation: Establishes the published case count at the time of the delineating cohort study.
- population: Individuals with genetically unsolved microphthalmia, anophthalmia, or coloboma
  measure_type: PERIOD_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 2200.0
  notes: >-
    Diagnostic yield rather than population prevalence: PRR12 loss-of-function
    variants accounted for 2.2 percent of previously unsolved MAC cases, and
    3.5 percent of unilateral MAC cases, in a research exome cohort. Recorded
    here because it is the only quantitative occurrence figure available and
    it establishes PRR12 as a non-negligible contributor to unilateral eye
    malformation, which historically has a very low genetic diagnostic rate.
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In this cohort, the apparent loss-of-function variants in PRR12 explained 4/182 (2.2%) of unsolved MAC including 2/57 (3.5%) cases with unilateral MAC."
    explanation: Quantifies the contribution of PRR12 to genetically unsolved microphthalmia, anophthalmia, and coloboma.
pathophysiology:
- name: PRR12 Truncating Variant with Nonsense-Mediated Decay
  biological_scale: MOLECULAR
  description: >-
    Nearly all reported pathogenic PRR12 alleles are protein-truncating:
    frameshift, nonsense, and splice-site variants, plus whole-gene deletion
    and a balanced translocation that disrupts the locus. Because the
    premature termination codons fall well upstream of the final exon-exon
    junction, the mutant transcripts are predicted to be degraded by
    nonsense-mediated decay; if decay is escaped, the residual protein is
    severely truncated and functionally deficient. Either route removes one
    functional copy of the gene, so the operative lesion is allele loss
    rather than a dominant-negative or gain-of-function protein.
  genes:
  - preferred_term: PRR12
    term:
      id: hgnc:29217
      label: PRR12
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12."
    explanation: Documents the predominantly truncating variant spectrum, including a whole-gene deletion consistent with allele loss.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All variants reported thus far are predicted to result in protein truncation and are likely subject to nonsense mediated decay, thus haploinsufficiency represents the most likely disease mechanism."
    explanation: States the nonsense-mediated-decay route from truncating allele to haploinsufficiency.
  - reference: PMID:26163108
    reference_title: "A de novo t(10;19)(q22.3;q13.33) leads to ZMIZ1/PRR12 reciprocal fusion transcripts in a girl with intellectual disability and neuropsychiatric alterations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The resulting hybrid transcripts predict mRNA decay or, if translated, formation of truncated proteins, both due to frameshifts that introduced premature stop codons."
    explanation: A structural rearrangement disrupting PRR12 converges on the same decay-or-truncation outcome, independent of point mutation.
  downstream:
  - target: PRR12 Haploinsufficiency
    description: Loss of one functional allele halves the dose of PRR12 protein.
- name: PRR12 Haploinsufficiency
  biological_scale: MOLECULAR
  description: >-
    PRR12 is highly intolerant of loss-of-function variation in population
    databases, so a single inactivated allele is not buffered. The gene
    encodes a proline-rich nuclear protein with suspected DNA-binding
    activity whose expression in the fetal brain and visual system is
    consistent with a dosage-sensitive developmental role. Reduced predicted
    PRR12 expression is itself associated with eye and kidney phenotypes in a
    transcriptome-imputation (PrediXcan) analysis of electronic health record
    phecodes, providing human genetic support for dosage sensitivity that is
    independent of the rare-variant case series.
  genes:
  - preferred_term: PRR12
    term:
      id: hgnc:29217
      label: PRR12
  cellular_components:
  - preferred_term: nucleus
    term:
      id: GO:0005634
      label: nucleus
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Predicted loss-of-function variants in this gene are extremely rare, indicating high intolerance of haploinsufficiency."
    explanation: Population constraint data establish PRR12 as dosage sensitive.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease."
    explanation: Transcriptome-imputation analysis independently links reduced PRR12 dosage to eye and kidney phenotypes, matching the two organ systems most affected in the rare-variant cohort.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities."
    explanation: The delineating study's conclusion that haploinsufficiency is the disease mechanism.
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In summary, we propose that haploinsufficiency of PRR12 is associated with this novel multisystem neurodevelopmental disorder."
    explanation: The founding report proposes haploinsufficiency as the mechanism.
  downstream:
  - target: Impaired Chromatin-Associated Transcriptional Regulation
    hypothesis_groups:
    - transcriptional_cofactor
    description: >-
      Reduced dosage of a nuclear DNA-binding cofactor lowers its contribution
      to developmental transcriptional programs.
  - target: Impaired NIPBL-Cohesin Cooperation and Genomic Instability
    hypothesis_groups:
    - cohesin_nipbl_axis
    description: >-
      Reduced PRR12 impairs cohesin loading and the DNA damage response, an
      emerging alternative or additional route to the developmental phenotype.
- name: Impaired Chromatin-Associated Transcriptional Regulation
  biological_scale: MOLECULAR
  description: >-
    PRR12 is a nuclear protein carrying two predicted AT-hook DNA-binding
    domains, with DNA-interacting domains that are highly conserved across
    vertebrates, and the prevailing model is that it functions as a cofactor
    in transcriptional regulation. Its coexpression neighborhood is enriched
    for chromatin regulators including SET-domain, bromodomain, zinc-finger,
    and BAH-domain proteins. Halving its dosage is proposed to perturb the
    transcriptional programs that pattern the developing forebrain and eye.
    The precise target genes, partner complexes, and DNA-binding specificity
    remain undefined, and PRR12 is still described in the primary literature
    as a gene of largely unknown function.
  molecular_functions:
  - preferred_term: DNA binding
    modifier: DECREASED
    term:
      id: GO:0003677
      label: DNA binding
  - preferred_term: chromatin binding
    modifier: DECREASED
    term:
      id: GO:0003682
      label: chromatin binding
  biological_processes:
  - preferred_term: regulation of DNA-templated transcription
    modifier: ABNORMAL
    term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
  cellular_components:
  - preferred_term: nucleus
    term:
      id: GO:0005634
      label: nucleus
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "PRR12 encodes a Proline-Rich Protein 12 of unknown function. Current evidence suggests that PRR12 functions as a cofactor in transcriptional regulation within the nucleus"
    explanation: States the transcriptional-cofactor model while making explicit that the protein's function is otherwise unknown; marked PARTIAL because the model is inferred rather than experimentally demonstrated.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "Proline Rich 12 (PRR12) is a gene of unknown function with suspected DNA-binding activity, expressed in developing mice and human brains."
    explanation: DNA-binding activity is suspected rather than established, so this supports the node's premise only partially.
  - reference: PMID:38674426
    reference_title: "Shedding a Light on Dark Genes: A Comparative Expression Study of PRR12 Orthologues during Zebrafish Development."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In silico analysis reveals high evolutionary conservation in the DNA-interacting domains for both orthologs"
    explanation: Deep conservation of the DNA-interacting domains in the zebrafish co-orthologs supports a conserved nucleic-acid-binding regulatory function.
  downstream:
  - target: Disrupted Neural Development
    hypothesis_groups:
    - transcriptional_cofactor
    description: Perturbed developmental transcription in the fetal brain.
  - target: Disrupted Ocular Morphogenesis
    hypothesis_groups:
    - transcriptional_cofactor
    description: Perturbed developmental transcription in the forming eye.
  - target: Disrupted Cardiac Organogenesis
    hypothesis_groups:
    - transcriptional_cofactor
    description: Perturbed developmental transcription in the cardiac primordium.
  - target: Disrupted Renal Organogenesis
    hypothesis_groups:
    - transcriptional_cofactor
    description: Perturbed developmental transcription in the developing kidney and ureteric bud.
- name: Impaired NIPBL-Cohesin Cooperation and Genomic Instability
  biological_scale: CELLULAR
  description: >-
    A co-essentiality screen identified PRR12 as a cohesin-associated factor.
    PRR12 physically interacts with the NIPBL/MAU2 cohesin loader and with the
    cohesin complex itself; its loss reduces cohesin localization and produces
    a substantial increase in DNA double-strand breaks, and PRR12 is recruited
    with NIPBL to sites of DNA damage in a NIPBL- and cohesin-dependent manner.
    Because NIPBL haploinsufficiency causes Cornelia de Lange syndrome, this
    places PRR12 adjacent to the cohesinopathies. Its curated explanatory scope
    here is deliberately limited to the neurodevelopmental arm, which is the
    only downstream edge this node asserts: impaired cohesin function and
    accumulating DNA damage in proliferating neural progenitors is a plausible
    route to developmental impairment, whereas no evidence connects this
    mechanism to the ocular, cardiac, or renal malformations, so those edges
    are not drawn. The evidence is cell-biological, comes principally from
    mouse NIH-3T3 cells, and has not yet been connected to patient tissue, so
    this is an emerging rather than an established disease mechanism.
  protein_complexes:
  - preferred_term: cohesin complex
    term:
      id: GO:0008278
      label: cohesin complex
  biological_processes:
  - preferred_term: sister chromatid cohesion
    modifier: DECREASED
    term:
      id: GO:0007062
      label: sister chromatid cohesion
  - preferred_term: double-strand break repair
    modifier: ABNORMAL
    term:
      id: GO:0006302
      label: double-strand break repair
  evidence:
  - reference: PMID:39742660
    reference_title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We show that PRR12 interacts with NIPBL/MAU2 and the cohesin complex, and that the loss of PRR12 results in reduced cohesin localization and a substantial increase in DNA double-strand breaks in mouse NIH-3T3 cells."
    explanation: Establishes the physical and functional link between PRR12, the NIPBL/MAU2 cohesin loader, and genome integrity.
  - reference: PMID:39742660
    reference_title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "PRR12 co-localizes with NIPBL to sites of DNA damage in a NIPBL and cohesin-dependent manner."
    explanation: Places PRR12 downstream of NIPBL and cohesin in the DNA damage response.
  - reference: PMID:39742660
    reference_title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: "We find that the requirement for PRR12 differs across cell lines, with human HeLa cells exhibiting reduced sensitivity to PRR12 loss compared with mouse NIH-3T3 cells, indicating context-specific roles."
    explanation: The authors' own caveat that PRR12 dependence is context specific and weaker in the human cell line tested, which limits direct extrapolation to human disease.
  downstream:
  - target: Disrupted Neural Development
    hypothesis_groups:
    - cohesin_nipbl_axis
    description: >-
      Impaired cohesin function and accumulating DNA damage in neural
      progenitors as a candidate route to the neurodevelopmental phenotype.
- name: Disrupted Neural Development
  biological_scale: TISSUE
  description: >-
    PRR12 is expressed in the nucleus of developing mouse and human brain, most
    strongly in fetal relative to adult brain, and in the zebrafish central
    nervous system from early development, with later expression in cerebellum,
    amygdala, and ventral telencephalon. Reduced dosage during forebrain
    development is the presumed substrate for the universal developmental
    impairment, the hypotonia, the microcephaly seen in a subset, and the
    neuropsychiatric features. Neural progenitor involvement is inferred from
    developmental expression rather than demonstrated in patient tissue.
  biological_processes:
  - preferred_term: nervous system development
    modifier: ABNORMAL
    term:
      id: GO:0007399
      label: nervous system development
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "PRR12 encodes a proline-rich protein nuclear factor suspected to be involved in neural development. Its nuclear expression in fetal brains and in the vision system supports its role in brain and eye development more specifically."
    explanation: Fetal brain expression links PRR12 dosage to neural development.
  - reference: PMID:38674426
    reference_title: "Shedding a Light on Dark Genes: A Comparative Expression Study of PRR12 Orthologues during Zebrafish Development."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "prr12a is expressed early in zygotic development, mainly in the central nervous system, while prr12b expression initiates during gastrulation, localizing later to dopaminergic telencephalic and diencephalic cell clusters."
    explanation: Zebrafish co-orthologs are expressed in the developing central nervous system, consistent with a conserved neurodevelopmental role.
  downstream:
  - target: Neurodevelopmental Impairment
    description: Abnormal brain development manifests as developmental delay and intellectual disability.
- name: Disrupted Ocular Morphogenesis
  biological_scale: TISSUE
  description: >-
    PRR12 is expressed in the developing visual system, and in zebrafish both
    co-orthologs are enriched in the ganglion cell and inner neural layers of
    the larval retina, with one also present in the ciliary marginal zone.
    Reduced PRR12 dosage during ocular morphogenesis produces a graded set of
    malformations: at the severe end failure of optic vesicle growth
    (anophthalmia and microphthalmia, in the most severe reported case with
    absent optic nerves, tracts, and chiasm), at the intermediate level failure
    of optic fissure closure (coloboma) and anterior segment dysgenesis (Peters
    anomaly, Rieger anomaly, stellate iris, microcornea), and at the mild end
    isolated iris, foveal, retinal, or optic nerve anomalies. A distinctive and
    unexplained feature is marked asymmetry: the malformation is frequently
    unilateral with a structurally normal contralateral eye, implying a
    stochastic or threshold-dependent rather than uniformly deterministic
    effect of the reduced dosage.
  biological_processes:
  - preferred_term: camera-type eye development
    modifier: ABNORMAL
    term:
      id: GO:0043010
      label: camera-type eye development
  cell_types:
  - preferred_term: retinal ganglion cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  locations:
  - preferred_term: eye
    term:
      id: UBERON:0000970
      label: eye
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."
    explanation: Defines the structural ocular malformation spectrum and its incomplete penetrance in the delineating cohort.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Remarkably, ocular phenotypes were asymmetric in all individuals and unilateral (with structurally normal contralateral eye) in three."
    explanation: Documents the characteristic asymmetry and unilaterality of the PRR12 eye malformation.
  - reference: PMID:38674426
    reference_title: "Shedding a Light on Dark Genes: A Comparative Expression Study of PRR12 Orthologues during Zebrafish Development."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Both transcripts are enriched in the ganglion cell and inner neural layers of the 72 hpf retina, with prr12b widely distributed in the ciliary marginal zone."
    explanation: Retinal expression of the zebrafish co-orthologs supports a direct role for PRR12 in eye development.
  downstream:
  - target: MAC-Spectrum and Anterior Segment Eye Malformation
    description: Disrupted ocular morphogenesis produces the observed structural eye defects.
- name: Disrupted Cardiac Organogenesis
  biological_scale: TISSUE
  description: >-
    Congenital heart defects are the commonest extra-neural, extra-ocular
    malformation, affecting about half of reported individuals; the lesions
    described are septal defects and pulmonary stenosis, that is, defects of
    septation and outflow-tract formation rather than a single anatomical
    lesion. The developmental basis is not established. Unlike the renal arm,
    the cardiac arm has no independent supporting signal beyond the case
    series, so it rests solely on the inference of a dosage-sensitive
    developmental transcriptional program.
  biological_processes:
  - preferred_term: heart development
    modifier: ABNORMAL
    term:
      id: GO:0007507
      label: heart development
  locations:
  - preferred_term: heart
    term:
      id: UBERON:0000948
      label: heart
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Quantifies cardiac malformation in the delineating cohort.
  downstream:
  - target: Congenital Heart Malformation
    description: Disrupted cardiac organogenesis manifests as structural heart defects.
- name: Disrupted Renal Organogenesis
  biological_scale: TISSUE
  description: >-
    Kidney and urinary tract anomalies affect about a third of reported
    individuals, with hydronephrosis, duplicated ureter, and vesicoureteral
    reflux reported - a collecting-system and ureteric-bud pattern rather than
    a parenchymal one. The renal arm is distinguished from the cardiac arm by
    having independent human genetic corroboration: renal phecodes were
    enriched among the phenotypes associated with reduced predicted PRR12
    expression in a transcriptome-imputation analysis, so two orthogonal lines
    of human evidence converge on the kidney.
  biological_processes:
  - preferred_term: kidney development
    modifier: ABNORMAL
    term:
      id: GO:0001822
      label: kidney development
  locations:
  - preferred_term: kidney
    term:
      id: UBERON:0002113
      label: kidney
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Quantifies renal malformation in the delineating cohort.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease."
    explanation: Transcriptome-imputation independently implicates the kidney as a dosage-sensitive PRR12 target organ; this snippet is renal- and ocular-specific and does not speak to the heart, which is why it is attached here rather than to the cardiac node.
  downstream:
  - target: Kidney and Urinary Tract Malformation
    description: Disrupted renal organogenesis manifests as structural kidney and urinary tract defects.
- name: Neurodevelopmental Impairment
  biological_scale: ORGANISM
  description: >-
    The clinical endpoint of the neural arm: developmental delay or impaired
    intellectual development, present in every individual in the delineating
    cohort, together with hypotonia and neuropsychiatric comorbidity. Severity
    ranges from mild learning difficulty to non-verbal cognitive impairment
    requiring full assistance, and a minority of individuals ascertained
    through ophthalmology have entirely normal development. The congenital
    malformations are static, but developmental capabilities may improve with
    maturation and intervention; no prospective natural-history data exist.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had developmental impairment."
    explanation: Developmental impairment is the one universal finding in the delineating cohort.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional phenotypic expansions included short stature and normal development/cognition, each noted in two individuals in this cohort, as well as absence of neuropsychiatric disorders in all."
    explanation: Refines rather than contradicts the universality claim - in an ophthalmology-ascertained cohort some individuals have normal cognition, so developmental impairment is not obligate.
- name: MAC-Spectrum and Anterior Segment Eye Malformation
  biological_scale: ORGANISM
  description: >-
    The clinical endpoint of the ocular arm: anophthalmia, microphthalmia,
    coloboma, Peters anomaly, stellate iris pattern, cataract, foveal
    hypoplasia, glaucoma, persistent fetal vasculature, and optic nerve
    anomalies, in variable and frequently asymmetric combinations. In
    ophthalmology-ascertained families the eye phenotype may be entirely
    isolated with no systemic features.
  locations:
  - preferred_term: eye
    term:
      id: UBERON:0000970
      label: eye
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The ocular phenotypes in our cohort were more severe than previously reported, with microphthalmia (4) or coloboma (1) seen in all five individuals, Peters anomaly in three, and cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each."
    explanation: Enumerates the range of structural ocular findings attributable to PRR12 loss of function.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The ocular phenotypes were isolated with no additional systemic features observed in two unrelated families."
    explanation: Documents that the eye malformation can occur as a nonsyndromic phenotype.
- name: Congenital Heart Malformation
  biological_scale: ORGANISM
  description: >-
    The clinical endpoint of the cardiac arm: structural congenital heart
    disease, present in about half of reported individuals and requiring
    echocardiographic screening at diagnosis. Atrial septal defect,
    ventricular septal defect, and pulmonary stenosis are the reported
    lesions; those specific types are from the delineating study's full text
    and are not abstract-verifiable.
  locations:
  - preferred_term: heart
    term:
      id: UBERON:0000948
      label: heart
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Establishes congenital heart malformation as a recurrent clinical endpoint.
- name: Kidney and Urinary Tract Malformation
  biological_scale: ORGANISM
  description: >-
    The clinical endpoint of the renal arm: structural kidney and urinary
    tract anomalies, present in about a third of reported individuals and
    requiring renal ultrasound at diagnosis. Hydronephrosis, duplicated
    ureter, and vesicoureteral reflux are the reported lesions; those
    specific types are from the delineating study's full text and are not
    abstract-verifiable.
  locations:
  - preferred_term: kidney
    term:
      id: UBERON:0002113
      label: kidney
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Establishes kidney and urinary tract malformation as a recurrent clinical endpoint.
mechanistic_hypotheses:
- hypothesis_group_id: transcriptional_cofactor
  hypothesis_label: PRR12 as a dosage-sensitive nuclear transcriptional cofactor
  status: CANONICAL
  description: >-
    The prevailing model: PRR12 is a nuclear, AT-hook-containing DNA-binding
    proline-rich protein acting as a transcriptional cofactor, and halving its
    dosage perturbs the developmental transcriptional programs of the brain,
    eye, heart, and kidney. It is the default explanation in every clinical
    report, but it is an inference from subcellular localization, expression
    pattern, domain prediction, and coexpression neighborhood rather than from
    demonstrated target genes or partner complexes; candidate interactors such
    as USP7, SOX2, and ESR2 have been nominated but are explicitly described by
    the delineating authors as experimentally unproven, and the primary
    literature continues to describe PRR12 as a gene of largely unknown
    function.
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "PRR12 encodes a Proline-Rich Protein 12 of unknown function. Current evidence suggests that PRR12 functions as a cofactor in transcriptional regulation within the nucleus"
    explanation: States the hypothesis and simultaneously flags that the protein's function is unknown.
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "PRR12 encodes a proline-rich protein nuclear factor suspected to be involved in neural development."
    explanation: A nuclear-factor role in neural development is suspected rather than demonstrated.
- hypothesis_group_id: cohesin_nipbl_axis
  hypothesis_label: PRR12 as a NIPBL/cohesin cofactor and genome-integrity factor
  status: EMERGING
  description: >-
    A 2025 co-essentiality screen recast PRR12 as a cohesin-associated protein
    that binds the NIPBL/MAU2 loader, supports cohesin localization, and limits
    DNA double-strand break accumulation. If this is the operative mechanism in
    patients, PRR12-related neuroocular syndrome would belong mechanistically
    with the cohesinopathies such as NIPBL-related Cornelia de Lange syndrome,
    which would predict shared features (growth failure, developmental
    impairment, multisystem malformation) that the observed clinical picture is
    at least compatible with. The hypothesis has not been tested in patient
    cells or in a developmental context, and the authors themselves report that
    the requirement for PRR12 is cell-line dependent and weaker in the human
    line they tested. See the prr12_cohesin_human_relevance discussion.
  evidence:
  - reference: PMID:39742660
    reference_title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "by analyzing patterns of similar gene requirements across cell lines, we identify PRR12 as a mediator of cohesin and genome integrity"
    explanation: The finding that generates this hypothesis.
  - reference: PMID:39742660
    reference_title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."
    supports: PARTIAL
    evidence_source: IN_VITRO
    snippet: "Together, our work identifies PRR12 as a regulator of cohesin and provides insight into how genome integrity is maintained across diverse cellular contexts."
    explanation: The claim is framed as general cell biology, not as a disease mechanism, so it supports the hypothesis only partially.
genetic:
- name: PRR12
  association: Heterozygous loss-of-function variant, usually de novo
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: PRR12
    term:
      id: hgnc:29217
      label: PRR12
  notes: >-
    Reported pathogenic alleles are overwhelmingly protein-truncating -
    frameshift, nonsense, and splice-site variants distributed across the gene
    from exon 4 to exon 13 of 14 - plus one gross deletion, two missense
    variants of less certain effect, and a balanced t(10;19) translocation
    generating ZMIZ1/PRR12 fusion transcripts. Most arose de novo; one
    splice-site allele was transmitted from an affected mother, and one
    frameshift allele showed skewed allele fractions on exome, genome, and
    Sanger sequencing consistent with somatic mosaicism. Co-occurring
    independent genetic diagnoses have been reported and can confound the
    phenotype, so a PRR12 finding does not exclude a second contributing
    variant.

    Transcript and allele detail from the delineating study's full text, not
    abstract-verifiable and therefore recorded here rather than as evidence
    items. The reference transcript is NM_020719.3 / ENST00000418929.7. A
    shorter transcript, ENST00000615927.1, encodes an approximately 130 kDa
    1,215-amino-acid isoform lacking exons 1 to 3 and most of exon 4; eight of
    the reported variants were predicted to spare this short isoform, but no
    statistically significant phenotypic difference was found between the
    isoform-sparing and isoform-disrupting groups, so isoform status is not
    currently a useful genotype-phenotype axis. Twenty-one distinct sequence
    variants were reported, including the recurrent c.1521T>G p.Tyr507* and
    c.3273delC p.Lys1092Argfs*131. The two missense alleles, c.3505C>T
    p.Arg1169Trp and c.5909T>C p.Leu1970Pro, had PolyPhen-2 scores of 0.998 and
    1.000 but remain less well supported mechanistically than the truncating
    alleles, since haploinsufficiency is inferred from truncation rather than
    demonstrated for missense change. Constraint metrics are pLI 1.00, an
    observed-to-expected loss-of-function ratio of 0.0 with a 90 percent
    confidence interval of 0 to 0.05, and LOEUF 0.051, with a missense Z score
    of 2.98. The gross-deletion case is confounded by loss of 146 other
    annotated genes including PPP2R1A, so it supports the locus but not PRR12
    specifically. No validated modifier gene or methylation episignature has
    been established, and no somatic disease mechanism is reported.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12."
    explanation: Defines the pathogenic allelic spectrum in the largest reported cohort.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Three individuals had additional genetic findings, possibly confounding the phenotype."
    explanation: Documents that co-occurring genetic diagnoses complicate genotype-phenotype attribution in this disorder.
  - reference: PMID:41357555
    reference_title: "De Novo GUCY2C and PRR12 Mutations in a Patient With Chronic Diarrhea, Small Bowel Obstructions, and Developmental Delay."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A co-occurring de novo PRR12 c.768del (p.Ala257Leufs*58) frameshift mutation explained his developmental delay."
    explanation: A worked example of dual molecular diagnosis in which the PRR12 frameshift accounts specifically for the neurodevelopmental component.
  - reference: PMID:26163108
    reference_title: "A de novo t(10;19)(q22.3;q13.33) leads to ZMIZ1/PRR12 reciprocal fusion transcripts in a girl with intellectual disability and neuropsychiatric alterations."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "fine mapping of breakpoints by array painting disclosed disruptions of the zinc finger, MIZ-type containing 1 (ZMIZ1) (on chr10) and proline-rich 12 (PRR12) (on chr19) genes"
    explanation: A structural variant disrupting PRR12; marked PARTIAL because the translocation simultaneously disrupts ZMIZ1, which is itself a neurodevelopmental disease gene, so causal attribution to PRR12 alone is not clean.
  - reference: PMID:41953648
    reference_title: "Exploring the molecular basis of microphthalmia and anophthalmia: Insights from an Egyptian cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."
    explanation: Independent replication of PRR12 as a microphthalmia and anophthalmia gene in a non-European cohort.
phenotypes:
- name: Developmental delay and impaired intellectual development
  category: Neurologic
  diagnostic: true
  frequency: VERY_FREQUENT
  description: >-
    The single most consistent feature. Every individual in the 24-person
    delineating cohort had developmental impairment, comprising global
    developmental delay in most and isolated motor or speech-language delay in
    a minority, and ranging from mild learning difficulty to severe cognitive
    impairment with absent speech and full dependence for daily activities.
    Ophthalmology-ascertained individuals may have normal cognition, so the
    finding is near-universal rather than obligate.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had developmental impairment."
    explanation: 24 of 24 individuals affected, supporting the VERY_FREQUENT band.
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."
    explanation: All three individuals in the founding series had global developmental delay.
- name: Intellectual disability
  category: Neurologic
  frequency: VERY_FREQUENT
  description: >-
    Intellectual disability of variable degree accompanies the developmental
    delay in most affected individuals, with mild to moderate impairment
    typical and severe non-verbal impairment reported. In the delineating
    cohort it was documented in all evaluable individuals over seven years of
    age, though that denominator is a full-text figure.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."
    explanation: Intellectual disability in 3 of 3 of the founding series, and it is the presenting feature in the translocation and single-case reports.
  - reference: PMID:38798311
    reference_title: "Case Report: Identification of a novel PRR12 variant in a Chinese boy with developmental delay and short stature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He was the first PRR12 deficiency patient in China and presented with ID, short stature, and mild scoliosis."
    explanation: Intellectual disability was the presenting feature in an independent single-case report.
- name: Microphthalmia
  category: Ophthalmologic
  diagnostic: true
  frequency: FREQUENT
  description: >-
    Small globe, frequently complex (with anterior segment dysgenesis) and
    characteristically asymmetric or unilateral. Microphthalmia is the
    commonest structural eye defect and the finding that most often prompts
    PRR12 testing in ophthalmic genetics. The FREQUENT band reflects the 50
    percent rate of structural eye defects overall in the delineating cohort
    and the 4 of 5 rate in the ophthalmology-ascertained cohort; the
    microphthalmia-specific rate in an unbiased population is unknown.
  phenotype_term:
    preferred_term: Microphthalmia
    term:
      id: HP:0000568
      label: Microphthalmia
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The ocular phenotypes in our cohort were more severe than previously reported, with microphthalmia (4) or coloboma (1) seen in all five individuals, Peters anomaly in three, and cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each."
    explanation: Microphthalmia in 4 of 5 individuals in the ophthalmic-genetics cohort.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."
    explanation: Structural eye defects including microphthalmia in 50 percent of the delineating cohort, supporting the FREQUENT band for the ocular phenotype overall.
- name: Anophthalmia
  category: Ophthalmologic
  description: >-
    Absent globe represents the severe end of the PRR12 ocular spectrum and is
    reported less often than microphthalmia; in the most severely affected
    reported individual it was bilateral with absent optic nerves, tracts, and
    chiasm on MRI. The combined anophthalmia and microphthalmia rate is
    quantified only in the full text of the delineating study, so no frequency
    band is asserted here.
  phenotype_term:
    preferred_term: Anophthalmia
    term:
      id: HP:0000528
      label: Anophthalmia
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."
    explanation: Anophthalmia is explicitly listed within the structural eye defect spectrum.
- name: Coloboma
  category: Ophthalmologic
  description: >-
    Failure of optic fissure closure. Most often affecting the iris, but optic
    nerve, macular, chorioretinal, and lens colobomas are also reported. Iris
    coloboma was one of the two consistent eye findings in the founding
    three-patient series. The cohort-level rate is a full-text figure, so no
    frequency band is asserted.
  phenotype_term:
    preferred_term: Coloboma
    term:
      id: HP:0000589
      label: Coloboma
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."
    explanation: Coloboma is part of the reported structural eye defect spectrum.
- name: Iris coloboma
  category: Ophthalmologic
  description: >-
    The specific coloboma subtype most consistently reported, present in two of
    the three individuals in the founding series and bilaterally in the
    ophthalmic-genetics cohort.
  phenotype_term:
    preferred_term: Iris coloboma
    term:
      id: HP:0000612
      label: Iris coloboma
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eye abnormalities were consistent among the three patients and consisted of stellate iris pattern and iris coloboma."
    explanation: Iris coloboma was one of the two consistent ocular findings in the founding series.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individual 2 displays a significant ocular phenotype with bilateral iris coloboma, foveal hypoplasia, and nystagmus"
    explanation: Bilateral iris coloboma in an individual with an otherwise isolated ocular phenotype.
- name: Stellate iris pattern
  category: Ophthalmologic
  description: >-
    A distinctive star-like iris stromal pattern reported in all three
    individuals of the founding series. HPO has no dedicated term for the
    stellate pattern, so this is bound to the parent term for abnormal iris
    morphology and the specific descriptor is carried in preferred_term.
  phenotype_term:
    preferred_term: Stellate iris pattern
    term:
      id: HP:0000525
      label: Abnormality iris morphology
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eye abnormalities were consistent among the three patients and consisted of stellate iris pattern and iris coloboma."
    explanation: Stellate iris pattern in 3 of 3 of the founding series.
- name: Peters anomaly
  category: Ophthalmologic
  description: >-
    Central corneal opacity with iridocorneal or keratolenticular adhesion, an
    anterior segment dysgenesis phenotype. Present in three of five individuals
    in the ophthalmic-genetics cohort, and its recognition extended the PRR12
    ocular phenotype beyond the MAC spectrum into anterior segment dysgenesis.
  phenotype_term:
    preferred_term: Peters anomaly
    term:
      id: HP:0000659
      label: Peters anomaly
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified four novel pathogenic loss-of-function alleles in PRR12 in families affected by complex microphthalmia and/or Peters anomaly, including two de novo, the first dominantly transmitted allele, as well as the first splicing variant."
    explanation: Peters anomaly is an ascertaining phenotype for PRR12 loss-of-function alleles.
- name: Abnormal optic nerve morphology
  category: Ophthalmologic
  description: >-
    Optic nerve anomalies are listed among the structural eye defects of the
    delineating cohort, with optic nerve hypoplasia and abnormal disc shape
    reported. The specific morphology is not resolved at abstract level, so
    the general parent term is used.
  phenotype_term:
    preferred_term: Optic nerve abnormality
    term:
      id: HP:0000587
      label: Abnormal optic nerve morphology
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities."
    explanation: Optic nerve abnormalities are explicitly enumerated in the structural eye defect spectrum.
- name: Cataract
  category: Ophthalmologic
  description: >-
    Lens opacity reported in a single individual of the ophthalmic-genetics
    cohort, alongside persistent fetal vasculature in the same eye.
  phenotype_term:
    preferred_term: Cataract
    term:
      id: HP:0000518
      label: Cataract
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each"
    explanation: Cataract reported in one individual of the ophthalmic cohort.
- name: Foveal hypoplasia
  category: Ophthalmologic
  description: >-
    Underdevelopment of the fovea, reported with nystagmus and bilateral iris
    coloboma in one individual who was otherwise systemically normal.
  phenotype_term:
    preferred_term: Foveal hypoplasia
    term:
      id: HP:0007750
      label: Hypoplasia of the fovea
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individual 2 displays a significant ocular phenotype with bilateral iris coloboma, foveal hypoplasia, and nystagmus"
    explanation: Foveal hypoplasia in an individual with an otherwise isolated ocular phenotype.
- name: Glaucoma
  category: Ophthalmologic
  description: >-
    Raised intraocular pressure with optic neuropathy, reported in one
    individual with bilateral Peters anomaly. Glaucoma is a recognized
    complication of anterior segment dysgenesis and warrants surveillance in
    affected eyes.
  phenotype_term:
    preferred_term: Glaucoma
    term:
      id: HP:0000501
      label: Glaucoma
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individual 3 was diagnosed with bilateral Peters anomaly, left microphthalmia and right glaucoma"
    explanation: Glaucoma documented in an individual with bilateral Peters anomaly.
- name: Nystagmus
  category: Ophthalmologic
  description: >-
    Involuntary rhythmic eye movement, reported bilaterally in individuals with
    early-onset structural eye disease.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the daughter also has Peters anomaly in the affected eye, bilateral nystagmus, and mild developmental delay/learning difficulties"
    explanation: Bilateral nystagmus documented in an individual with a transmitted PRR12 splice variant.
- name: Strabismus
  category: Ophthalmologic
  description: >-
    Ocular misalignment, reported as exotropia in the earliest described
    individuals and as strabismus with myopia in the translocation case. It is
    among the commonest functional ocular findings and is surgically
    manageable.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "this individual was similarly affected with intellectual disability, anxiety/autistic like features, and myopia with strabismus, but had normal irises"
    explanation: Strabismus documented in an individual with PRR12 disruption by translocation.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "iris coloboma was present in two of the three, a stellate iris pattern was reported in all three, and myopia and exotropia were also seen"
    explanation: Exotropia, a form of strabismus, in the founding three-patient series.
- name: Visual impairment
  category: Ophthalmologic
  description: >-
    Reduced visual function is the commonest ocular consequence and is more
    frequent than any individual structural malformation, because it also
    arises from amblyopia, refractive error, and optic nerve involvement in
    eyes without a gross globe defect. It was present in all three individuals
    of the founding series and, per the delineating study's full text, in 17 of
    22 assessed individuals. That 77 percent denominator is not in the cached
    abstract, so no frequency band is asserted here. Visual impairment is the
    functional target of low-vision rehabilitation.
  phenotype_term:
    preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."
    explanation: The founding series documents vision abnormalities, as distinct from structural eye abnormalities, in all three individuals.
- name: Generalized hypotonia
  category: Neurologic
  frequency: FREQUENT
  description: >-
    Reduced muscle tone was reported in 61 percent of the delineating cohort,
    presenting during or persisting beyond the neonatal period, and features
    among the variable findings of the founding series.
  phenotype_term:
    preferred_term: Generalized hypotonia
    term:
      id: HP:0001290
      label: Generalized hypotonia
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Hypotonia in 61 percent of the cohort maps to the FREQUENT band, 30 to 79 percent.
- name: Congenital heart defect
  category: Cardiovascular
  frequency: FREQUENT
  description: >-
    Structural cardiac malformation was reported in 52 percent of the
    delineating cohort; the specific lesions described in the full text were
    atrial septal defect, ventricular septal defect, and pulmonary stenosis.
    Echocardiographic screening is warranted at diagnosis.
  phenotype_term:
    preferred_term: Congenital heart defect
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Heart defects in 52 percent of the cohort maps to the FREQUENT band.
- name: Growth failure
  category: Growth
  frequency: FREQUENT
  description: >-
    Failure to thrive and postnatal growth failure were reported in 54 percent
    of the delineating cohort, and feeding and nutritional support is a
    recurring management need.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Growth failure in 54 percent of the cohort maps to the FREQUENT band.
- name: Short stature
  category: Growth
  frequency: OCCASIONAL
  description: >-
    Short stature was a phenotypic expansion recognized in the
    ophthalmic-genetics cohort, in two of five individuals, and is the
    presenting complaint in independent single-case reports; one such case had
    low insulin-like growth factor 1, suggesting a possible endocrine
    contribution that has not been systematically examined.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional phenotypic expansions included short stature and normal development/cognition, each noted in two individuals in this cohort, as well as absence of neuropsychiatric disorders in all."
    explanation: Short stature in 2 of 5 individuals, newly recognized as part of the PRR12 phenotype; reported conservatively as OCCASIONAL because it is not a documented feature of the larger neurodevelopmentally ascertained series.
  - reference: PMID:38798311
    reference_title: "Case Report: Identification of a novel PRR12 variant in a Chinese boy with developmental delay and short stature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The insulin-like growth factor 1 (IGH-1) was low in our patient, which may be the cause of his short stature."
    explanation: Independent case with short stature and a candidate endocrine mechanism.
- name: Kidney anomaly
  category: Renal
  frequency: FREQUENT
  description: >-
    Structural kidney and urinary tract anomalies, reported in 35 percent of
    the delineating cohort and including hydronephrosis, duplicated ureter, and
    vesicoureteral reflux. Renal phecodes were independently enriched among the
    phenotypes associated with reduced predicted PRR12 expression. Renal
    ultrasound is warranted at diagnosis.
  phenotype_term:
    preferred_term: Abnormality of the kidney
    term:
      id: HP:0000077
      label: Abnormality of the kidney
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Kidney anomalies in 35 percent of the cohort maps to the FREQUENT band.
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease."
    explanation: Independent transcriptome-imputation support for renal involvement.
- name: Microcephaly
  category: Neurologic
  description: >-
    Reduced occipitofrontal head circumference is listed among the common
    systemic features in the MONDO and OMIM disease definitions, and the
    delineating study's full text reports it in roughly a quarter of
    individuals. That figure is not in the cached abstract, so no frequency
    band is asserted.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities."
    explanation: Microcephaly is documented in the full text of the delineating cohort and in the derived OMIM and MONDO definitions, but the abstract quantifies only hypotonia, heart, growth, and kidney features; this evidence item therefore supports the disorder framing only partially and the specific microcephaly claim is not abstract-verifiable.
- name: Autism spectrum behavior
  category: Neuropsychiatric
  description: >-
    Autistic features were reported among the behavioral issues of the founding
    series and in the translocation case. Notably, no neuropsychiatric
    diagnoses were present in the ophthalmology-ascertained cohort, so this
    feature is strongly ascertainment dependent and no reliable cohort
    frequency is extractable.
  phenotype_term:
    preferred_term: Autism
    term:
      id: HP:0000717
      label: Autism
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."
    explanation: Autistic behavior is a reported variable feature in the founding series.
- name: Anxiety
  category: Neuropsychiatric
  description: >-
    Anxiety is reported among the neuropsychiatric problems in
    neurodevelopmentally ascertained individuals and was absent in the
    ophthalmology-ascertained cohort.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."
    explanation: Anxiety is a reported variable behavioral feature.
- name: Attention deficit hyperactivity disorder
  category: Neuropsychiatric
  description: >-
    ADHD has been formally diagnosed in reported individuals and contributes to
    educational difficulty independently of the intellectual disability.
  phenotype_term:
    preferred_term: Attention deficit hyperactivity disorder
    term:
      id: HP:0007018
      label: Attention deficit hyperactivity disorder
  evidence:
  - reference: PMID:38798311
    reference_title: "Case Report: Identification of a novel PRR12 variant in a Chinese boy with developmental delay and short stature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He could not concentrate on his studies and was diagnosed with attention deficit hyperactivity disorder (ADHD)."
    explanation: Formal ADHD diagnosis in a reported individual.
- name: Sleep disturbance
  category: Neurologic
  description: >-
    Sleeping problems are listed among the variable clinical features of the
    founding series; no systematic sleep study data exist for this disorder.
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."
    explanation: Sleeping problems are a reported variable feature of the founding series.
- name: Abnormal facial shape
  category: Craniofacial
  description: >-
    Dysmorphic facial features are consistently noted - wide-set eyes,
    epicanthal folds, low-set ears, upturned nasal tip, and thin vermilion each
    occurred in at least a quarter of the delineating cohort - but the authors
    found no recognizable gestalt, so the facial phenotype is not diagnostically
    useful on its own.
  phenotype_term:
    preferred_term: Dysmorphic facial features
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."
    explanation: Dysmorphic features in 3 of 3 of the founding series.
- name: Scoliosis
  category: Musculoskeletal
  description: >-
    Skeletal abnormalities including scoliosis are reported as variable
    features.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:38798311
    reference_title: "Case Report: Identification of a novel PRR12 variant in a Chinese boy with developmental delay and short stature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He was the first PRR12 deficiency patient in China and presented with ID, short stature, and mild scoliosis."
    explanation: Mild scoliosis reported in an independent case.
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional variable clinical features included hypotonia, skeletal abnormalities, sleeping problems, and behavioral issues such as autism and anxiety."
    explanation: Skeletal abnormalities are reported generically, without scoliosis being named, so this supports the claim only partially.
diagnosis:
- name: Trio exome or genome sequencing
  description: >-
    Molecular diagnosis rests on identifying a heterozygous loss-of-function
    PRR12 variant or deletion by exome or genome sequencing in an appropriate
    phenotype, with parental testing to establish de novo status. Trio testing
    is efficient because the phenotype is broad and usually de novo. Genome
    sequencing better detects structural and noncoding variants, and
    chromosomal microarray is appropriate when multiple congenital anomalies
    suggest a copy-number change. Two practical points recur in the reported
    series. First, PRR12 variants have repeatedly been found only on re-review
    of previously non-diagnostic exome data, so reanalysis is worthwhile.
    Second, several reported variants showed skewed allele fractions consistent
    with mosaicism, so a low variant allele fraction should not lead to
    automatic dismissal.
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report on three unrelated patients with heterozygous de novo apparent loss-of-function mutations in PRR12 detected by clinical whole exome sequencing"
    explanation: Clinical exome sequencing is the established diagnostic route.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the results from Sanger sequencing were also consistent with mosaicism, showing lower peaks for the mutant allele"
    explanation: Documents mosaicism as a recognized complication of variant interpretation in this gene.
- name: Bilateral ophthalmological assessment
  description: >-
    Detailed bilateral ophthalmological examination is essential at diagnosis.
    Because the eye phenotype is frequently unilateral with a structurally
    normal fellow eye, examining only the obviously affected side will
    misclassify the phenotype, and conversely a normal examination in one eye
    does not exclude PRR12-related disease. Anterior segment assessment should
    specifically look for Peters anomaly, stellate iris pattern, and iris
    coloboma; posterior segment and optic nerve assessment is needed because
    posterior abnormalities were under-ascertained in the reported cohort; and
    affected eyes require glaucoma surveillance.
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Remarkably, ocular phenotypes were asymmetric in all individuals and unilateral (with structurally normal contralateral eye) in three."
    explanation: Justifies bilateral examination and the caution against inferring bilateral normality.
- name: Cardiac and renal screening
  description: >-
    Because congenital heart defects and kidney anomalies each affect a
    substantial minority of individuals, echocardiography and renal ultrasound
    are indicated at the time of molecular diagnosis, with growth and feeding
    monitoring alongside.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: The frequency of cardiac and renal malformation justifies systematic screening.
differential_diagnoses:
- name: SOX2-related anophthalmia/microphthalmia syndrome
  disease_term:
    preferred_term: SOX2 anophthalmia syndrome
    term:
      id: MONDO:0008799
      label: anophthalmia/microphthalmia-esophageal atresia syndrome
  description: >-
    SOX2 is the single commonest cause of syndromic anophthalmia and
    microphthalmia and shares the core PRR12 combination of a severe
    MAC-spectrum eye malformation with developmental delay. Both genes appear
    side by side in the diagnostic yield of the same
    anophthalmia/microphthalmia sequencing cohorts, and both have been reported
    to produce unilateral ocular anomalies, so SOX2 is the first alternative to
    exclude.
  distinguishing_features:
  - Oesophageal atresia and tracheo-oesophageal fistula are characteristic of the SOX2 syndrome and are not features of PRR12-related disease.
  - Hypogonadotropic hypogonadism and genital anomalies point to SOX2 rather than PRR12.
  - PRR12-related eye disease is characteristically asymmetric or unilateral, whereas SOX2 anophthalmia is more often bilateral and more uniformly severe.
  - Congenital heart and kidney defects are prominent in PRR12-related disease and are not part of the SOX2 core pattern.
  evidence:
  - reference: PMID:41953648
    reference_title: "Exploring the molecular basis of microphthalmia and anophthalmia: Insights from an Egyptian cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."
    explanation: SOX2 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort, establishing them as members of one differential.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "While genes such as SOX2 and OTX2 have been occasionally reported to cause unilateral ocular anomalies"
    explanation: Places SOX2 and OTX2 alongside PRR12 as the genes capable of producing unilateral developmental ocular anomalies, which is the specific diagnostic scenario in which PRR12 is easily missed.
- name: OTX2-related syndromic microphthalmia
  disease_term:
    preferred_term: syndromic microphthalmia type 5
    term:
      id: MONDO:0012413
      label: syndromic microphthalmia type 5
  description: >-
    OTX2 haploinsufficiency causes a dominant, largely de novo MAC-spectrum
    disorder with optic nerve involvement and developmental delay, closely
    mirroring the PRR12 presentation. As with SOX2, OTX2 is recovered from the
    same diagnostic cohorts and can produce unilateral disease.
  distinguishing_features:
  - Pituitary hormone deficiency, including combined pituitary hormone deficiency, is a recognized OTX2 feature and has not been reported as part of the PRR12 phenotype.
  - Retinal dystrophy with an abnormal electroretinogram is more characteristic of OTX2 than of PRR12.
  - Anterior segment dysgenesis with Peters anomaly and a stellate iris pattern favours PRR12.
  - Congenital heart and kidney malformations are common in PRR12-related disease and are not core OTX2 features.
  evidence:
  - reference: PMID:41953648
    reference_title: "Exploring the molecular basis of microphthalmia and anophthalmia: Insights from an Egyptian cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."
    explanation: OTX2 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort.
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "While genes such as SOX2 and OTX2 have been occasionally reported to cause unilateral ocular anomalies"
    explanation: OTX2 shares with PRR12 the capacity to cause unilateral ocular anomalies.
- name: CHARGE syndrome and the wider CHD7 disorder spectrum
  disease_term:
    preferred_term: CHARGE syndrome
    term:
      id: MONDO:0008965
      label: CHARGE syndrome
  description: >-
    The most important syndromic differential, because CHARGE syndrome
    reproduces almost the entire PRR12 multisystem pattern, namely coloboma,
    heart defect, growth and developmental delay, and renal anomalies. Both are
    dominant, typically de novo, chromatin-associated disorders, since CHD7 is
    a chromatin remodeller and PRR12 a chromatin-associated nuclear protein, so
    the mechanistic as well as the clinical overlap is real. CHD7 also appears
    with PRR12 in the same MAC diagnostic cohorts.
  distinguishing_features:
  - Choanal atresia is a cardinal CHARGE feature and is not reported in PRR12-related disease.
  - Semicircular canal hypoplasia and cranial nerve anomalies, including anosmia and facial palsy, are highly discriminating for CHD7.
  - Characteristic external ear anomalies with deafness point to CHARGE.
  - Genital hypoplasia and hypogonadotropic hypogonadism favour CHARGE.
  - Anterior segment dysgenesis with Peters anomaly favours PRR12, whereas the CHARGE ocular lesion is characteristically a chorioretinal or optic nerve coloboma.
  evidence:
  - reference: PMID:20301296
    reference_title: "CHD7 Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness)."
    explanation: GeneReviews enumerates the CHARGE cardinal features, showing both the overlap with PRR12 in coloboma, heart defect, and growth and developmental delay, and the discriminators of choanal atresia, genital hypoplasia, and ear anomalies.
  - reference: PMID:20301296
    reference_title: "CHD7 Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies"
    explanation: The expanded CHD7 spectrum includes renal anomalies, completing the eye, heart, and kidney overlap with PRR12 and making cranial nerve and vestibular assessment the practical discriminator.
  - reference: PMID:41953648
    reference_title: "Exploring the molecular basis of microphthalmia and anophthalmia: Insights from an Egyptian cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The implicated genes were SOX2, OTX2, CHD7, HMX1, PRR12, ATOH7, ZBTB11, B3GALNT2, GCNT2, DPH1, GJA8, FRAS1 and UBE3B."
    explanation: CHD7 and PRR12 are recovered from the same anophthalmia and microphthalmia diagnostic cohort.
- name: PAX2-related disorder, formerly renal coloboma syndrome
  disease_term:
    preferred_term: renal coloboma syndrome
    term:
      id: MONDO:0007352
      label: renal coloboma syndrome
  description: >-
    A dominant disorder pairing renal anomalies with optic nerve anomalies,
    precisely the eye-plus-kidney combination that PRR12 produces, and
    therefore a natural differential when a child presents with coloboma and a
    structural renal anomaly. It offers an unusually clean discriminator.
  distinguishing_features:
  - Iris coloboma has not been reported in PAX2-related disorder, so an iris coloboma argues against it and towards PRR12.
  - The PAX2 ocular lesion is specifically optic nerve coloboma or dysplasia, not the globe-size and anterior-segment defects seen with PRR12.
  - Renal involvement in PAX2-related disorder is near-obligate and progresses to renal insufficiency or end-stage renal disease, whereas PRR12 renal anomalies affect a minority and are structural rather than progressive.
  - Congenital heart defects and significant developmental delay are not core PAX2 features but are common in PRR12-related disease.
  evidence:
  - reference: PMID:20301624
    reference_title: "PAX2-Related Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Iris colobomas have not been reported in any individual with PAX2–related disorder."
    explanation: GeneReviews provides a near-absolute discriminator, since iris coloboma is a recurrent PRR12 finding and argues against PAX2-related disorder.
  - reference: PMID:20301624
    reference_title: "PAX2-Related Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals."
    explanation: The near-obligate renal involvement in PAX2-related disorder contrasts with the roughly one-third rate in PRR12-related disease, so a child with severe progressive renal disease plus optic nerve coloboma is more likely to have PAX2-related disorder.
- name: SALL4-related disorders, including acro-renal-ocular syndrome
  disease_term:
    preferred_term: Duane-radial ray syndrome
    term:
      id: MONDO:0011812
      label: Duane-radial ray syndrome
  description: >-
    The acro-renal-ocular phenotype within the SALL4 spectrum combines ocular
    coloboma, renal anomalies, and cardiac malformation, overlapping the PRR12
    eye-heart-kidney triad, and the associated eye movement disorder can be
    mistaken for the strabismus seen in PRR12-related disease. The renal lesions
    overlap closely, including vesicoureteral reflux, which is also reported in
    PRR12-related disease.
  distinguishing_features:
  - Radial ray malformation, meaning thumb hypoplasia or aplasia, triphalangeal or duplicated thumb, and radial hypoplasia, is the defining SALL4 feature and is absent in PRR12-related disease.
  - Duane anomaly, a congenital cranial dysinnervation disorder with globe retraction on adduction, is distinct from the common comitant strabismus of PRR12-related disease.
  - Anterior segment dysgenesis with Peters anomaly and microphthalmia favours PRR12, whereas the SALL4 ocular lesion is characteristically a coloboma.
  - Significant intellectual disability is typical of PRR12-related disease and is not a core SALL4 feature.
  evidence:
  - reference: PMID:20301547
    reference_title: "SALL4-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "AROS is characterized by radial ray malformations, renal abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, vesicoureteral reflux, bladder diverticula), ocular coloboma, and Duane anomaly."
    explanation: The acro-renal-ocular phenotype overlaps PRR12 on coloboma and renal anomaly including vesicoureteral reflux, while the radial ray malformation supplies the discriminator.
  - reference: PMID:20301547
    reference_title: "SALL4-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "DRRS is characterized by uni- or bilateral Duane anomaly and radial ray malformation that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs"
    explanation: Confirms that limb involvement is the defining SALL4 feature, which examination of the thumbs and forearms will resolve.
- name: PAX6 aniridia syndrome and the wider PAX6-related spectrum
  disease_term:
    preferred_term: isolated aniridia
    term:
      id: MONDO:0007119
      label: isolated aniridia
  description: >-
    Phenotypically the closest ocular mimic of PRR12-related disease, and
    arguably the most instructive differential in this entry, because PAX6
    reproduces nearly the whole curated PRR12 feature list, including foveal
    hypoplasia, glaucoma, cataract, optic nerve coloboma and hypoplasia,
    nystagmus, and microphthalmia, together with developmental delay or
    intellectual disability, autism, ADHD, anxiety, and disordered sleep. The
    MONDO binding used here is the aniridia term, but the intended comparator
    is the wider PAX6-related spectrum, which includes non-aniridic anterior
    segment phenotypes.
  distinguishing_features:
  - Partial or complete iris hypoplasia, that is aniridia, and corneal keratopathy with limbal stem cell failure are PAX6 hallmarks not seen in PRR12-related disease.
  - Interocular symmetry is the sharpest discriminator, because PAX6 disease is usually near-symmetric between the two eyes whereas PRR12 disease is asymmetric in essentially all reported individuals and frequently unilateral.
  - A stellate iris pattern with iris coloboma favours PRR12 over the iris hypoplasia of PAX6.
  - Congenital heart defects and kidney anomalies are part of the PRR12 phenotype and are not features of PAX6 aniridia syndrome; a WT1 deletion causing WAGR syndrome should instead be considered when aniridia occurs with renal disease.
  evidence:
  - reference: PMID:20301534
    reference_title: "PAX6 Aniridia Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Classic aniridia affects the iris (partial or full iris hypoplasia), cornea (corneal keratopathy), anterior segment (resulting in raised intraocular pressure and glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia)."
    explanation: The PAX6 ocular feature list overlaps the curated PRR12 ocular phenotypes almost item for item, which is why iris hypoplasia and corneal keratopathy must be sought as discriminators.
  - reference: PMID:20301534
    reference_title: "PAX6 Aniridia Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Although the severity of aniridia shows interfamilial and intrafamilial variability, little variability is usually observed in the two eyes of an affected individual."
    explanation: Provides the sharpest discriminator against PRR12, whose defining ocular feature is marked asymmetry between the two eyes, often with one structurally normal eye.
  - reference: PMID:20301534
    reference_title: "PAX6 Aniridia Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "developmental delay / intellectual disability; neurobehavioral/psychiatric manifestations such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and behavioral dysregulation; and mood disorders such as depression and anxiety"
    explanation: The PAX6 neurodevelopmental and neuropsychiatric profile matches the PRR12 profile closely, so the neurobehavioural phenotype cannot be used to separate the two and discrimination must rest on ocular and visceral features.
treatments:
- name: Physical Therapy
  description: >-
    There is no disease-modifying therapy, gene therapy, RNA therapy, or
    PRR12-targeted treatment for this disorder, and no interventional trial
    has been registered. Management is supportive and multidisciplinary.
    Physical therapy addresses the hypotonia and the motor component of the
    developmental delay.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  target_phenotypes:
  - preferred_term: Generalized hypotonia
    term:
      id: HP:0001290
      label: Generalized hypotonia
  target_mechanisms:
  - target: Neurodevelopmental Impairment
    treatment_effect: MODULATES
    description: >-
      Symptomatic support that may improve motor function without addressing
      the underlying haploinsufficiency.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: Hypotonia in 61 percent of the cohort establishes the indication for physical therapy; the cohort study does not itself evaluate any intervention, so this is indirect support only.
- name: Occupational Therapy
  description: >-
    Occupational therapy supports adaptive and daily-living skills. It is
    particularly relevant in this disorder because the combination of
    developmental impairment with visual impairment compounds functional
    disability, and because severity ranges up to full dependence for
    activities of daily living.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: occupational therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  target_mechanisms:
  - target: Neurodevelopmental Impairment
    treatment_effect: MODULATES
    description: >-
      Symptomatic support for adaptive function; does not address the
      underlying haploinsufficiency.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had developmental impairment."
    explanation: Universal developmental impairment establishes the indication; the cohort study evaluates no intervention, so support is indirect.
- name: Speech and Language Therapy
  description: >-
    Speech and language therapy addresses the expressive language deficit.
    This is a distinct need rather than a generic add-on: a subset of
    individuals in the delineating cohort had isolated speech-language delay
    as their only developmental impairment, and at the severe end individuals
    are non-verbal.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  target_mechanisms:
  - target: Neurodevelopmental Impairment
    treatment_effect: MODULATES
    description: >-
      Symptomatic support for communication; does not address the underlying
      haploinsufficiency.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients had developmental impairment."
    explanation: Universal developmental impairment, which per the full text includes isolated speech-language delay in a subset, establishes the indication; the cohort study evaluates no intervention.
- name: Ophthalmic Surgical Management
  description: >-
    Surgical management of the structural ocular malformation: strabismus
    surgery, corneal or cataract surgery where indicated for Peters anomaly or
    lens opacity, glaucoma surgery or intraocular pressure control, and
    prosthetic or socket care for anophthalmia and severe microphthalmia. No
    intervention restores the developmental malformation itself. Because the
    disease is characteristically asymmetric, surgical planning must protect
    the function of the better-seeing eye.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: ophthalmologic surgical procedure
    term:
      id: NCIT:C15331
      label: Ophthalmologic Surgical Procedure
  target_phenotypes:
  - preferred_term: Peters anomaly
    term:
      id: HP:0000659
      label: Peters anomaly
  - preferred_term: Cataract
    term:
      id: HP:0000518
      label: Cataract
  - preferred_term: Glaucoma
    term:
      id: HP:0000501
      label: Glaucoma
  - preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  target_mechanisms:
  - target: MAC-Spectrum and Anterior Segment Eye Malformation
    treatment_effect: MODULATES
    description: >-
      Addresses the consequences of the structural eye malformation rather
      than the morphogenetic defect.
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "The ocular phenotypes in our cohort were more severe than previously reported, with microphthalmia (4) or coloboma (1) seen in all five individuals, Peters anomaly in three, and cataract, foveal hypoplasia, abnormal vascular development, glaucoma and hyperopia in one case each."
    explanation: The enumerated surgically and optically manageable lesions establish the indication; the report does not evaluate treatment outcomes, so support is indirect.
- name: Low Vision Rehabilitation and Refractive Management
  description: >-
    Non-surgical visual management, split out from the surgical entry because
    it is a rehabilitative rather than an operative modality: low-vision
    services and aids, refractive correction, and amblyopia therapy. Amblyopia
    therapy is especially important in this disorder because the malformation
    is frequently unilateral, so the structurally normal fellow eye is at risk
    of deprivation amblyopia if the affected eye is simply written off.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:29556724
    reference_title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "All three patients had global developmental delay, intellectual disability, eye and vision abnormalities, dysmorphic features, and neuropsychiatric problems."
    explanation: Vision abnormalities in all three individuals of the founding series establish the indication for visual rehabilitation; no study evaluates the intervention, so support is indirect.
- name: Cardiac and Renal Surveillance and Supportive Care
  description: >-
    Standard cardiology management of septal defects and pulmonary stenosis,
    and nephrology or urology management of hydronephrosis, vesicoureteral
    reflux, and duplicated collecting systems, alongside nutritional and
    feeding support for the growth failure. No disorder-specific surveillance
    guideline exists; care follows the general standards for each individual
    malformation.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Congenital Heart Malformation
    treatment_effect: MODULATES
    description: >-
      Manages the cardiac malformation endpoint; does not alter the
      developmental cause.
  - target: Kidney and Urinary Tract Malformation
    treatment_effect: MODULATES
    description: >-
      Manages the renal malformation endpoint; does not alter the
      developmental cause.
  evidence:
  - reference: PMID:33824499
    reference_title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%)."
    explanation: The frequency of cardiac, renal, and growth involvement establishes the indication for surveillance and supportive care; the cohort study evaluates no intervention.
- name: Genetic Counseling
  description: >-
    Counseling should cover the autosomal dominant mechanism, the predominantly
    de novo origin with correspondingly low but non-zero recurrence risk from
    parental germline mosaicism, the theoretical 50 percent transmission risk
    for an affected individual, the documented instance of parent-to-child
    transmission, and the wide and currently unpredictable phenotypic
    variability, including the possibility of an affected relative with
    isolated unilateral eye disease and normal cognition. Reproductive options
    after molecular diagnosis include prenatal diagnosis and preimplantation
    genetic testing.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:33314030
    reference_title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Given the variability observed in reported individuals thus far, it seems likely that additional phenotypic variation will be identified as more PRR12 variants are discovered."
    explanation: The authors' explicit statement of unresolved phenotypic variability is what counseling must convey.
discussions:
- discussion_id: prr12_eye_penetrance
  prompt: >-
    Why is the PRR12 ocular malformation present in only about half of affected
    individuals, and why is it so frequently unilateral with a structurally
    normal contralateral eye?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Disrupted Ocular Morphogenesis
  - pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation
  rationale: >-
    Incomplete and markedly asymmetric penetrance of a malformation caused by a
    constitutional heterozygous null allele is mechanistically informative. A
    uniformly deterministic dosage effect would predict bilateral, roughly
    symmetric disease. Unilaterality instead implies that ocular morphogenesis
    crosses a stochastic threshold independently in each optic vesicle, or that
    a somatic second hit, modifier locus, or transcriptional noise determines
    which eye is affected. No genotype-phenotype correlation explains it: the
    most N-terminal and the most C-terminal reported variants both produce eye
    disease, and cohort ascertainment route rather than allele position
    predicts the reported eye involvement rate. Resolving this bears directly
    on counseling, since a parent with an isolated unilateral eye anomaly may
    carry the same allele as a severely affected child.
  proposed_experiments:
  - experiment_id: prr12-eye-somatic-asymmetry
    name: Somatic and allele-specific analysis of discordant fellow eyes
    description: >-
      In individuals with unilateral disease from whom ocular tissue is
      available at surgery, compare somatic variant burden and allele-specific
      PRR12 expression between the malformed and the structurally normal eye to
      test whether a somatic second hit or skewed allelic expression explains
      the laterality.
    readouts:
    - name: Difference in somatic variant burden and PRR12 allelic ratio between fellow eyes
      target: "pathophysiology#Disrupted Ocular Morphogenesis"
  - experiment_id: prr12-eye-stochastic-threshold
    name: Left-right concordance test in a bilateral eye-development model
    description: >-
      Model PRR12 haploinsufficiency in a system that forms bilateral optic
      vesicles and score left-right concordance of the malformation against the
      concordance predicted by a stochastic-threshold model versus a
      deterministic dosage model.
    readouts:
    - name: Left-right concordance rate of optic vesicle malformation
      target: "pathophysiology#Disrupted Ocular Morphogenesis"
  - experiment_id: prr12-eye-modifier-screen
    name: Modifier screen in PRR12 carriers stratified by eye involvement
    description: >-
      Test for enrichment of rare and common variants in known MAC and
      anterior-segment-dysgenesis genes in PRR12 loss-of-function carriers,
      stratified by presence, severity, and laterality of eye involvement.
    readouts:
    - name: Modifier allele burden by eye-involvement stratum
      target: "pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation"
- discussion_id: prr12_cohesin_human_relevance
  prompt: >-
    Does the PRR12-NIPBL/cohesin interaction and its DNA double-strand break
    phenotype, demonstrated principally in mouse NIH-3T3 cells, operate in the
    human developmental contexts that are affected in PRR12-related neuroocular
    syndrome?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability
  rationale: >-
    The cohesin finding is the first concrete molecular function assigned to
    PRR12 and would reclassify this disorder as a cohesinopathy adjacent to
    NIPBL-related Cornelia de Lange syndrome. But the evidence is explicitly
    context dependent: the authors report that human HeLa cells are less
    sensitive to PRR12 loss than mouse NIH-3T3 cells. Neither cell type is a
    neural progenitor, an optic vesicle cell, or a patient-derived line, and
    neither is heterozygous in the way patients are, since the experiments used
    complete loss rather than haploinsufficiency. Evidence for the mechanism
    therefore exists, but its translational validity to the human developmental
    phenotype is the open question, which is what distinguishes this from a
    plain absence of evidence. If the human requirement for PRR12 in cohesin
    loading is genuinely weak, the transcriptional-cofactor hypothesis remains
    the better explanation for the malformation pattern.
  proposed_experiments:
  - experiment_id: prr12-cohesin-patient-cells
    name: Cohesin and DNA damage phenotype in patient-derived human cells
    description: >-
      Test cohesin localization and double-strand break accumulation in PRR12
      heterozygous patient-derived iPSCs and in iPSC-derived neural progenitors
      and retinal organoids, rather than in immortalized cell lines, and at
      heterozygous rather than null dosage.
    readouts:
    - name: Cohesin chromatin occupancy and double-strand break burden in patient-derived neural and retinal cells
      target: "pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability"
  - experiment_id: prr12-vs-nipbl-comparison
    name: Direct comparison of PRR12 and NIPBL haploinsufficiency
    description: >-
      Compare the transcriptomic and chromatin-architecture consequences of
      PRR12 haploinsufficiency with those of NIPBL haploinsufficiency in the
      same human cell type to test the cohesinopathy classification directly.
    readouts:
    - name: Overlap of differentially expressed genes and altered chromatin contacts between PRR12 and NIPBL haploinsufficiency
      target: "pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability"
  - experiment_id: prr12-cdls-rephenotyping
    name: Systematic re-phenotyping for Cornelia de Lange features
    description: >-
      Assess whether individuals with PRR12-related neuroocular syndrome show
      any Cornelia de Lange-associated features such as characteristic facies,
      limb reduction defects, hirsutism, or gastroesophageal reflux on
      systematic re-phenotyping, which would clinically corroborate the
      cohesinopathy hypothesis.
    readouts:
    - name: Frequency of Cornelia de Lange-associated features in PRR12 carriers
      target: "pathophysiology#Impaired NIPBL-Cohesin Cooperation and Genomic Instability"
- discussion_id: prr12_ascertainment_bias
  prompt: >-
    What are the true population frequencies of eye involvement and cognitive
    impairment in PRR12 haploinsufficiency, once ascertainment bias is removed?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Developmental delay and impaired intellectual development
  - phenotypes#Microphthalmia
  rationale: >-
    The two principal cohorts disagree sharply in a way that is fully explained
    by how they were assembled. The neurodevelopmental matchmaking cohort
    reports developmental impairment in 100 percent and structural eye defects
    in 50 percent; the ophthalmic-genetics MAC and anterior-segment cohort
    reports eye defects in 100 percent, normal development and cognition in two
    of five, and no neuropsychiatric diagnoses at all. Both sets of figures are
    conditional on the ascertaining phenotype and neither is a population
    estimate. The curated frequency bands in this entry inherit that bias and
    should be revised when an unbiased series exists.
  proposed_experiments:
  - experiment_id: prr12-unbiased-cohort
    name: Ascertainment-neutral PRR12 variant cohort
    description: >-
      Assemble a PRR12 loss-of-function carrier cohort from unselected genome
      sequencing, such as a population biobank or newborn sequencing programme,
      rather than from phenotype-driven referral, and re-derive feature
      frequencies for eye involvement, cognition, and organ malformation.
    readouts:
    - name: Ascertainment-neutral frequency of structural eye defect and of developmental impairment
      target: "phenotypes#Microphthalmia"
  - experiment_id: prr12-relative-examination
    name: Ophthalmological examination of first-degree relatives
    description: >-
      Systematically examine all first-degree relatives of probands with slit
      lamp, dilated fundoscopy, and axial length measurement to detect mildly
      or unilaterally affected transmitting carriers who would otherwise be
      classified as unaffected.
    readouts:
    - name: Proportion of clinically unaffected first-degree relatives with a detectable subclinical ocular anomaly
      target: "pathophysiology#MAC-Spectrum and Anterior Segment Eye Malformation"
references:
- reference: PMID:33824499
  title: "Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities."
- reference: PMID:33314030
  title: "Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia."
- reference: PMID:29556724
  title: "De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities."
- reference: PMID:39742660
  title: "Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity."

📚

References & Deep Research

References

PMID:33824499

Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities.

No top-level findings curated for this source.

PMID:33314030

Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia.

No top-level findings curated for this source.

PMID:29556724

De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities.

No top-level findings curated for this source.

PMID:39742660

Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity.

No top-level findings curated for this source.

Deep Research

Falcon ▸

PRR12-Related Neuroocular Syndrome: Disease Characteristics Report

Edison Scientific Literature 3 citations 2026-08-01T17:59:30.107734

PRR12-Related Neuroocular Syndrome: Disease Characteristics Report

Executive summary and evidence scope

PRR12-related neuroocular syndrome is an ultra-rare, autosomal-dominant developmental disorder caused primarily by heterozygous loss of PRR12 function. Its defining combination is developmental impairment—often intellectual disability—with highly variable congenital ocular abnormalities and frequent cardiac, renal, growth, and hypotonia phenotypes. The principal disease-defining study remains Chowdhury et al., published in Genetics in Medicine in July 2021 (accepted 11 February 2021; DOI: 10.1038/s41436-021-01129-6). It assembled 24 individuals, aged 5 months–36 years, including 11 females and 13 males. Focused searches did not identify a disease-specific 2023–2024 cohort, natural-history study, clinical guideline, or therapeutic trial; therefore, “current understanding” still rests predominantly on this 2021 cohort and earlier ocular case reports. A PMID was not recoverable from the retrieved material, so the DOI is supplied rather than an uncertain PMID. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 1-2)

The authors’ abstract-level conclusion is directly applicable: “These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities.” (chowdhury2021haploinsufficiencyofprr12 pages 1-2)

Domain	Summary	Evidence type	Key citations
Definition	PRR12-related neuroocular syndrome is a newly delineated Mendelian developmental disorder caused by PRR12 haploinsufficiency, characterized chiefly by developmental impairment/intellectual disability with variable structural and functional eye abnormalities plus multisystem involvement.	Observed human cohort evidence	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Evidence cohort	Disease-defining cohort: 24 individuals total, including 3 previously reported and 21 newly added; sex distribution 11 female/13 male; age range 5 months-36 years. Four additional DECIPHER individuals with de novo PRR12 variants and one additional DECIPHER microdeletion involving PRR12 were noted as supportive evidence.	Observed human cohort evidence	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 2-3)
Inheritance	Variants were de novo when parental testing/sequencing was possible; pattern is consistent with autosomal dominant disease due to haploinsufficiency. No established evidence for recessive inheritance, anticipation, or founder effect.	Observed human cohort evidence with interpretation	(chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Gene / variant mechanism	PRR12 encodes a 211-kDa nuclear protein with suspected DNA-binding activity. In the 24-patient cohort: 12 frameshift, 6 nonsense, 1 splice-site, 2 missense variants, and 1 gross deletion involving PRR12. Truncating/splice variants are predicted loss-of-function via nonsense-mediated decay; the overall disease mechanism is haploinsufficiency. Two de novo missense variants were predicted damaging in silico: c.3505C>T (p.Arg1169Trp) and c.5909T>C (p.Leu1970Pro). PRR12 is highly constrained for loss-of-function variation (pLI 1.00; o/e 0.0, 90% CI 0-0.05; LOEUF 0.051).	Observed human genetic evidence; some mechanistic prediction	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 2-3, chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Core phenotype frequencies	Developmental impairment: all sequence-variant cases described; among 23 with sequence variants, 17 global developmental delay, 3 isolated motor delay, 4 isolated speech-language delay. Intellectual disability documented in all 11/11 individuals older than 7 years with available data. Structural eye defects in 12/24 (50%). Globe defects/anophthalmia or microphthalmia in 4/24 (16.7%), observed only in females in this cohort. Coloboma in 7/24 (29%). Visual impairment in 17/22 (77%). Strabismus in 8/22 (36%).	Observed human cohort evidence	(chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)
Other systemic frequencies	Hypotonia 14/23 (61%). Congenital heart defects 12/23 (52%) including atrial septal defects (6), ventricular septal defects (2), pulmonary stenosis (3), with one patient having two defects. Kidney anomalies 8/23 (35%), including hydronephrosis, duplicated ureters, and vesicoureteral reflux. Failure to thrive 13/24 (54%). Microcephaly 7/24 (29%). Cleft palate 4/24 (17%). Intestinal malrotation 2/24 (8%). Meckel diverticulum 1/24 (4%). Cryptorchidism 5/13 males (38%).	Observed human cohort evidence	(chowdhury2021haploinsufficiencyofprr12 pages 6-8, chowdhury2021haploinsufficiencyofprr12 pages 8-9)
Expression / mechanism	Observed: PRR12 is ubiquitously expressed, with highest levels reported in brain (especially cerebellum/pituitary), thyroid, and female reproductive tissues; protein is nuclear-localized; fetal mouse and fetal human brain expression exceeds adult brain expression. PRR12 is associated with poised chromatin regions in embryonic/iPSC/neural progenitor contexts. Hypothesis: PRR12 likely functions in early neurodevelopment and transcriptional/chromatin regulation, possibly involving AT-hook-mediated DNA binding and networks enriched for transcription factors, chromatin regulators, SET-domain proteins, bromodomain proteins, and candidate interactors such as USP7, SOX2, and ESR2; these interactions remain unproven experimentally.	Mixed: observed expression/bioinformatic evidence; mechanistic hypotheses clearly labeled	(chowdhury2021haploinsufficiencyofprr12 pages 9-10, chowdhury2021haploinsufficiencyofprr12 pages 10-11)
Diagnosis	Current diagnosis is gene-first and molecular, typically via exome/genome sequencing or other broad genomic testing, supported by the recurrent phenotype of developmental impairment plus variable ocular anomalies. A PRR12-containing microdeletion can also support diagnosis. Ophthalmologic evaluation is important because some posterior-chamber defects may be missed on physical exam; incomplete eye assessments were a study limitation. ClinVar submissions were reported for several variants.	Observed human cohort evidence with practical diagnostic implication	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8, chowdhury2021haploinsufficiencyofprr12 pages 10-11)
Management	No disease-specific therapy or standardized treatment algorithm was established in the evidence reviewed. Management is supportive and phenotype-directed in practice, especially developmental services and organ-system evaluation (ophthalmology, cardiology, nephrology) based on observed multisystem involvement; however, explicit surveillance guidelines were not provided in the paper.	Evidence gap / limited inference from observed phenotype	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)
Epidemiology	Prevalence and incidence are not established. Evidence consists of rare case aggregation and database-supported cases. PRR12 loss-of-function variants are extremely rare in population databases, supporting rarity and intolerance to haploinsufficiency.	Observed rarity / evidence gap	(chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Trials / therapies	No relevant interventional clinical trials were identified in the available search results. No gene therapy, RNA therapy, or targeted therapy specific to PRR12-related neuroocular syndrome was established in the available evidence.	Evidence gap	(chowdhury2021haploinsufficiencyofprr12 pages 1-2)
Key limitations	Phenotypic variability is substantial. Three individuals had additional genetic findings that could confound attribution. Some ophthalmologic evaluations were incomplete. Genotype-phenotype correlation remains uncertain, especially regarding isoform-specific effects. Functional evidence is limited mainly to expression/bioinformatic data; animal-model validation and mechanistic studies were explicitly called for.	Observed study limitations and explicit author uncertainty	(chowdhury2021haploinsufficiencyofprr12 pages 6-8, chowdhury2021haploinsufficiencyofprr12 pages 10-11, chowdhury2021haploinsufficiencyofprr12 pages 9-10)

Table: This table condenses the current disease-defining evidence for PRR12-related neuroocular syndrome into knowledge-base-ready fields. It separates observed human findings from mechanistic hypotheses and highlights where evidence is still lacking.

1. Disease information

Definition and names

The preferred descriptive name is PRR12-related neuroocular syndrome. Literature alternatives include PRR12-related disorder, PRR12 haploinsufficiency disorder, and neurodevelopmental, eye, and multisystem abnormalities due to PRR12 haploinsufficiency. “Dominant complex microphthalmia due to PRR12 variants” describes the ocular-predominant end of the spectrum rather than every affected person, because 12/24 had no documented structural eye defect. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Identifiers

Gene: PRR12 (proline rich 12); historical alias KIAA1205.
Locus: chromosome 19q13.33–q13.41 region; the disease-causing sequence variants are intragenic, while one reported patient had a 3.352-Mb deletion spanning chr19:50,012,428–53,364,114 (hg19) and many additional genes. (chowdhury2021haploinsufficiencyofprr12 pages 3-4, chowdhury2021haploinsufficiencyofprr12 pages 9-10)
MONDO, Orphanet, disease-specific OMIM, MeSH, ICD-10, and ICD-11 identifiers: no dedicated identifier was verified in the retrieved evidence. A knowledge base should not assign a code without direct database confirmation. Existing ICD/HPO terms can encode component manifestations, but not the molecular syndrome itself.

The evidence is an aggregated disease-level case series, assembled through clinical genetics teams and matchmaking platforms, not a population EHR cohort. A separate PrediXcan analysis used BioVU electronic health records from approximately 25,000 genotyped European Americans, but it examined associations with genetically predicted PRR12 expression and does not establish syndrome prevalence or penetrance. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 8-9)

2. Etiology, risk, and protective factors

The primary cause is a germline heterozygous pathogenic PRR12 alteration, usually arising de novo. The supported mechanism is haploinsufficiency. Truncating and splice variants introduce premature termination codons before the penultimate exon and are predicted to undergo nonsense-mediated mRNA decay. (chowdhury2021haploinsufficiencyofprr12 pages 2-3, chowdhury2021haploinsufficiencyofprr12 pages 2-2)

No environmental, infectious, toxic, lifestyle, occupational, or dietary causal factor has been demonstrated. No protective allele, modifier gene, protective exposure, or gene–environment interaction has been established. Additional diagnoses may modify individual presentations: three cohort members carried other clinically relevant variants, including PIK3CA, KDM6B, and LZTR1 findings, making attribution of every feature to PRR12 uncertain. (chowdhury2021haploinsufficiencyofprr12 pages 8-9, chowdhury2021haploinsufficiencyofprr12 pages 9-10)

3. Phenotypes

The following frequencies are from the 24-person disease-defining cohort and should not be interpreted as population prevalence.

Neurodevelopment

Developmental impairment: present in all reported sequence-variant cases; 17 had global developmental delay, 3 isolated motor delay, and 4 isolated speech-language delay. Suggested terms: HP:0001263 Global developmental delay, HP:0001270 Motor delay, and HP:0000750 Delayed speech and language development. (chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Intellectual disability: documented in all 11 evaluable individuals older than seven years, ranging from mild to severe. Suggested term: HP:0001249 Intellectual disability. (chowdhury2021haploinsufficiencyofprr12 pages 2-2)
Hypotonia: 14/23 (61%), during or beyond the neonatal period. Suggested term: HP:0001252 Hypotonia. (chowdhury2021haploinsufficiencyofprr12 pages 8-9)
Behavioral observations included ADHD, autism-spectrum features, aggression, repetitive or self-injurious behavior in individual cases, but reliable cohort frequencies were not extractable. No validated behavioral profile is established. (chowdhury2021haploinsufficiencyofprr12 pages 5-6)

Eye and visual system

Any structural eye abnormality: 12/24 (50%).
Anophthalmia/microphthalmia: 4/24 (16.7%); all four were female in this small cohort. Suggested terms: HP:0000528 Anophthalmia, HP:0000568 Microphthalmia.
Coloboma: 7/24 (29%), most often iris but also optic nerve, macula, chorioretina, and lens; HP:0000589 Coloboma and site-specific child terms.
Visual impairment: 17/22 (77%); HP:0000505 Visual impairment.
Strabismus: 8/22 (36%); HP:0000486 Strabismus.
Other reported structures included retinal dysplasia, persistent pupillary membrane, Rieger anomaly, optic-nerve hypoplasia or abnormal shape, retinal pigment-epithelium hypertrophy, ptosis, and nystagmus. Patient 1 had bilateral anophthalmia with absent optic nerves, tracts, and chiasm on MRI. (chowdhury2021haploinsufficiencyofprr12 pages 2-3, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Eye severity therefore ranges from no apparent structural defect to bilateral anophthalmia and profound visual disability. Four individuals lacked complete ophthalmological assessment, so posterior abnormalities may be under-ascertained. (chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Multisystem findings

Congenital heart defect: 12/23 (52%): six atrial septal defects, two ventricular septal defects, and three pulmonary stenoses, with one person having two defects. Suggested terms: HP:0001627 Abnormal heart morphology, HP:0001631 Atrial septal defect, HP:0001629 Ventricular septal defect, HP:0001642 Pulmonic stenosis. (chowdhury2021haploinsufficiencyofprr12 pages 6-8)
Kidney/urinary anomaly: 8/23 (35%), including hydronephrosis, duplicated ureter, and vesicoureteral reflux. Suggested umbrella term: HP:0012210 Abnormal renal morphology, plus the corresponding specific HPO terms. (chowdhury2021haploinsufficiencyofprr12 pages 6-8)
Failure to thrive: 13/24 (54%); HP:0001508 Failure to thrive.
Microcephaly: 7/24 (29%); HP:0000252 Microcephaly.
Cryptorchidism: 5/13 males (38%); HP:0000028 Cryptorchidism.
Cleft palate: 4/24 (17%); HP:0000175 Cleft palate.
Intestinal malrotation: 2/24 (8%); HP:0002566 Intestinal malrotation.
Meckel diverticulum: 1/24 (4%). (chowdhury2021haploinsufficiencyofprr12 pages 8-9, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Facial findings—wide-set eyes, epicanthal folds, low-set ears, upturned nasal tip, and thin vermilion—each occurred in at least 25%, but the authors found no recognizable gestalt. (chowdhury2021haploinsufficiencyofprr12 pages 8-9, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

No disease-specific EQ-5D, SF-36, PROMIS, educational-attainment, caregiver-burden, or quality-of-life study exists. Nevertheless, intellectual disability, visual impairment, feeding/growth difficulty, and congenital organ disease plausibly impair communication, learning, mobility, and independent functioning; this is clinical inference, not a measured outcome.

4. Genetic and molecular information

The cohort contained 12 frameshift, 6 nonsense, 1 splice-site, 2 missense variants, and one gross deletion. Twenty-one distinct sequence variants were represented. Examples include recurrent c.1521T>G (p.Tyr507) and c.3273delC (p.Lys1092Argfs131), and the missense changes c.3505C>T (p.Arg1169Trp) and c.5909T>C (p.Leu1970Pro). The missense changes had PolyPhen-2 scores of 0.998 and 1.000 but remain less directly supported mechanistically than truncating alleles. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 2-3)

PRR12 is strongly constrained against loss of function: pLI 1.00, observed/expected LOF ratio 0.0 (90% CI 0–0.05), and LOEUF 0.051; its missense Z score was +2.98. These are population-constraint metrics, not patient-specific pathogenicity criteria. Disease alleles are germline; no somatic disease mechanism is reported. (chowdhury2021haploinsufficiencyofprr12 pages 2-2)

The main transcript used was NM_020719.3/ENST00000418929.7. A shorter 1,215-amino-acid, approximately 130-kDa isoform (ENST00000615927.1) omits exons 1–3 and most of exon 4. Eight variants were predicted to spare this short isoform, but phenotype differences between isoform groups were not statistically significant. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 10-11)

No validated modifier gene, methylation episignature, allele-specific expression biomarker, or pathogenic structural rearrangement restricted solely to PRR12 has been established. The large deletion case is informative but confounded by loss of 146 annotated genes, including PPP2R1A. (chowdhury2021haploinsufficiencyofprr12 pages 9-10)

5. Environmental information

Environmental contributors, infectious triggers, smoking, alcohol, diet, exercise, radiation, pollution, and occupational exposures are not implicated. This is a constitutional Mendelian developmental disorder. Standard healthy-lifestyle measures remain appropriate but are not disease-preventive.

6. Mechanism and pathophysiology

Evidence-supported causal chain

A heterozygous truncating/splice/deletion allele reduces functional PRR12 dosage, usually through nonsense-mediated decay.
PRR12 is a nuclear protein expressed strongly during fetal brain development and in the mouse visual system.
Reduced dosage during embryonic development likely disrupts developmental gene regulation in neural, ocular, cardiac, and renal progenitor programs.
Abnormal morphogenesis produces congenital ocular and organ defects; altered neural development produces delay, intellectual disability, and hypotonia. Steps 1–2 are supported; steps 3–4 remain a biologically plausible model rather than experimentally proven pathway mapping. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 9-10, chowdhury2021haploinsufficiencyofprr12 pages 2-3)

PRR12 contains two predicted AT-hook DNA-binding domains and is restricted to the nucleus. Coexpression neighborhoods are enriched for transcriptional regulation, chromatin regulators, SET-domain proteins, bromodomain proteins, zinc-finger proteins, and BAH-domain proteins. Candidate interactions with USP7, SOX2, and ESR2 could connect PRR12 to neurodevelopment and eye formation, but the authors emphasize that these interactions and consequences remain experimentally unproven. (chowdhury2021haploinsufficiencyofprr12 pages 10-11)

A useful exact quotation is: “The exact role of PRR12 in transcriptional regulation remains unclear and will require further functional studies to elucidate.” (chowdhury2021haploinsufficiencyofprr12 pages 10-11)

Suggested annotations, all provisional except nuclear localization: GO:0005634 nucleus; GO:0006355 regulation of DNA-templated transcription; GO:0007420 brain development; GO:0001654 eye development; GO:0048856 anatomical structure development; candidate cell types CL:0000047 neuronal stem cell and CL:0000127 astrocyte/other neural lineage terms only where future evidence supports them. No validated metabolic, immune, inflammatory, autophagic, mitochondrial, lipidomic, metabolomic, proteomic, single-cell, spatial-transcriptomic, CRISPR-screen, or multi-omic disease signature is available.

7. Anatomical structures affected

Primary systems are the central nervous system and eye; frequent secondary involvement includes heart, kidney/urinary tract, craniofacial structures, gastrointestinal tract, and male genital tract. Suggested UBERON annotations include UBERON:0000955 brain, UBERON:0000970 eye, UBERON:0000948 heart, and UBERON:0002113 kidney. Ocular disease may involve globe, iris, optic nerve, retina/choroid, macula, lens, and visual pathways. Findings may be unilateral, bilateral, or asymmetric; severe globe defects were not uniformly bilateral. (chowdhury2021haploinsufficiencyofprr12 pages 2-3, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

At the subcellular level, PRR12 localizes to the nucleus (GO:0005634). Specific vulnerable human cell populations have not been established experimentally. Neural progenitor involvement is inferred from developmental expression and poised chromatin observations, not demonstrated by patient single-cell data. (chowdhury2021haploinsufficiencyofprr12 pages 9-10)

8. Temporal development

The disorder is congenital/developmental. Structural eye, heart, kidney, palate, and gastrointestinal abnormalities arise prenatally; hypotonia may be neonatal or persist beyond that period. Developmental delay becomes apparent in infancy or childhood, while intellectual disability is assessable later. The available ages span 5 months–36 years. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 8-9)

There are no defined stages, progression rate, remission pattern, critical treatment window, or prospective natural-history data. Congenital malformations are generally static, whereas developmental capabilities may change with maturation and intervention. Whether retinal, renal, or neuropsychiatric manifestations progress is unknown.

9. Inheritance and population

The pattern is autosomal dominant, predominantly de novo. Recurrence risk for unaffected parents is usually low but not zero because parental germline mosaicism cannot be excluded; an affected individual would theoretically have a 50% transmission risk per pregnancy, subject to currently uncertain penetrance and expressivity. No familial multigenerational series establishes penetrance. Expressivity is clearly variable, especially for ocular severity. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

No incidence, prevalence, carrier frequency, founder effect, consanguinity association, ethnic enrichment, geographic concentration, anticipation, or reliable sex ratio exists. The cohort’s 11:13 female-to-male distribution does not demonstrate sex bias. The female-only globe defects are hypothesis-generating because only four such cases occurred. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

10. Diagnostics

Diagnosis requires identification of a pathogenic/likely pathogenic heterozygous PRR12 variant or deletion in an appropriate phenotype, followed by segregation testing. Trio exome or genome sequencing is efficient because the phenotype is broad and frequently de novo. Genome sequencing may better detect structural and noncoding variants; chromosomal microarray is appropriate when multiple congenital anomalies suggest a copy-number change. Single-gene sequencing or a neurodevelopmental/anophthalmia–microphthalmia–coloboma panel is reasonable when PRR12 is included. Karyotype/FISH can characterize a suspected translocation but are not first-line for small sequence variants. Mitochondrial and repeat-expansion tests have no disease-specific role. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 9-10)

Baseline phenotyping should include formal pediatric ophthalmology—not merely external inspection—developmental and neurologic assessment, growth/head circumference, echocardiography, renal ultrasound, hearing assessment, and examination for palate, genital, and gastrointestinal anomalies. This is phenotype-directed expert synthesis; no society guideline has yet standardized surveillance. Incomplete ophthalmologic examination demonstrably risks missing posterior defects. (chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Differential diagnoses include SOX2-related anophthalmia, OTX2-related disease, PAX6 disorders, CHD7/CHARGE syndrome, PAX2 renal-coloboma syndrome, and SALL4-related acro-renal-ocular/Okihiro spectrum. PRR12 disease is distinguished molecularly and by its combination of developmental impairment with variable eye, cardiac, renal, and growth findings. (chowdhury2021haploinsufficiencyofprr12 pages 10-11, chowdhury2021haploinsufficiencyofprr12 pages 9-10)

No biochemical assay, circulating biomarker, diagnostic methylation signature, biopsy finding, or validated RNA/proteomic/metabolomic test exists.

11. Outcomes and prognosis

No survival curve, mortality rate, life-expectancy estimate, prospective adult cohort, or prognostic biomarker exists. The oldest reported participant was 36 years, demonstrating survival into adulthood but not normal life expectancy. Morbidity is driven by intellectual/developmental disability, visual impairment, hypotonia, feeding/growth problems, and congenital organ defects. (chowdhury2021haploinsufficiencyofprr12 pages 2-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8)

Recovery of congenital structural defects is not expected, although developmental function and adaptive skills may improve with therapy. Prognosis should be individualized according to visual severity, level of intellectual disability, feeding/growth status, and cardiac/renal disease. These predictors are clinically reasonable but have not been statistically validated for this syndrome.

12. Treatment and current applications

There is no disease-modifying drug, gene therapy, RNA therapy, cell therapy, or PRR12-targeted treatment, and no relevant registered interventional trial was identified. Management is supportive and multidisciplinary:

early developmental, speech-language, occupational, and physical therapy;
low-vision services, refractive/amblyopia treatment, and surgical management of strabismus, cataract, glaucoma risk, coloboma complications, or anophthalmic sockets as individually indicated;
standard cardiology care for septal defects or pulmonary stenosis;
nephrology/urology care for hydronephrosis, reflux, or duplicated collecting systems;
nutritional/feeding support and growth monitoring;
standard treatment of cleft palate, cryptorchidism, and intestinal malrotation;
behavioral and educational supports.

Suggested NCIT intervention concepts include Genetic Counseling, Physical Therapy, Occupational Therapy, Speech Therapy, Supportive Care, and the appropriate procedure-specific concepts. No response-rate, comparative-effectiveness, adverse-event, pharmacogenomic, or combination-therapy data are available.

13. Prevention

The causal de novo event cannot presently be prevented through lifestyle or vaccination. Primary prevention is therefore limited to reproductive options after molecular diagnosis: genetic counseling, parental testing, prenatal diagnosis, and preimplantation genetic testing. Secondary prevention consists of early molecular diagnosis and prompt identification of ocular, cardiac, renal, feeding, and developmental complications. Tertiary prevention is multidisciplinary surveillance and rehabilitation intended to reduce avoidable visual loss, developmental disability, renal injury, and cardiac morbidity. Population newborn or carrier screening is not supported by current evidence.

14. Other species and natural disease

PRR12 coding sequence is conserved among vertebrates, and developmental mouse expression is strongest in fetal E15 brain relative to adult brain; expression in the mouse visual system has also been reported. However, no naturally occurring PRR12-associated veterinary syndrome, breed predisposition, zoonotic potential, or cross-species transmission is known. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 9-10)

Suggested taxa for comparative work are Homo sapiens (NCBI Taxon 9606), Mus musculus (10090), and Danio rerio (7955). Ortholog-specific NCBI Gene identifiers should be confirmed directly before database loading.

15. Model organisms and research priorities

No published PRR12 knockout/knock-in animal model was identified that demonstrably recapitulates the human neuroocular syndrome. No patient-derived iPSC, organoid, or validated cellular disease model was found. The disease-defining authors explicitly stated that mouse and zebrafish models would be valuable for defining PRR12 function and pathogenetic mechanisms. (chowdhury2021haploinsufficiencyofprr12 pages 10-11)

Priority studies are:

heterozygous and conditional Prr12 knockout mice to test brain, eye, heart, and kidney morphogenesis;
zebrafish knockdown/knockout with rescue by human wild-type and variant PRR12;
patient-derived neural and retinal organoids to assess dosage-sensitive transcriptional programs;
RNA sequencing, chromatin accessibility, DNA methylation, and protein-interaction studies;
prospective natural-history and standardized ophthalmology cohorts;
functional comparison of truncating and missense alleles and the long versus short isoforms.

Overall assessment

The gene–disease relationship is strongly supported for heterozygous PRR12 loss of function by recurrent de novo truncating alleles, population constraint, a consistent developmental phenotype, and supportive ocular cases. The best-established clinical statistics are developmental impairment in essentially all reported individuals, structural eye defects in 50%, visual impairment in 77% of those assessed, hypotonia in 61%, heart defects in 52%, failure to thrive in 54%, and renal anomalies in 35%. Mechanism beyond haploinsufficiency remains preliminary: developmental nuclear gene regulation and chromatin-associated function are credible hypotheses, but not yet a validated signaling pathway. The major unmet needs are a contemporary expanded cohort, prospective natural history, functional models, formal diagnostic criteria, surveillance guidance, and disease-modifying therapy. (chowdhury2021haploinsufficiencyofprr12 pages 1-2, chowdhury2021haploinsufficiencyofprr12 pages 6-8, chowdhury2021haploinsufficiencyofprr12 pages 10-11)

References

(chowdhury2021haploinsufficiencyofprr12 pages 2-2): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 1-2): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 2-3): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 6-8): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 8-9): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 9-10): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 10-11): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 3-4): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.
(chowdhury2021haploinsufficiencyofprr12 pages 5-6): Fuad Chowdhury, Lei Wang, Mohammed Al-Raqad, David J. Amor, Alice Baxová, Šárka Bendová, Elisa Biamino, Alfredo Brusco, Oana Caluseriu, Nancy J. Cox, Tawfiq Froukh, Meral Gunay-Aygun, Miroslava Hančárová, Devon Haynes, Solveig Heide, George Hoganson, Tadashi Kaname, Boris Keren, Kenjiro Kosaki, Kazuo Kubota, Jennifer M. Lemons, Maria A. Magriña, Paul R. Mark, Marie T. McDonald, Sarah Montgomery, Gina M. Morley, Hidenori Ohnishi, Nobuhiko Okamoto, David Rodriguez-Buritica, Patrick Rump, Zdeněk Sedláček, Krista Schatz, Haley Streff, Tomoko Uehara, Jagdeep S. Walia, Patricia G. Wheeler, Antje Wiesener, Christiane Zweier, Koichi Kawakami, Ingrid M. Wentzensen, Seema R. Lalani, Victoria M. Siu, Weimin Bi, and Tugce B. Balci. Haploinsufficiency of prr12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities. Genetics in Medicine, 23:1234-1245, Jul 2021. URL: https://doi.org/10.1038/s41436-021-01129-6, doi:10.1038/s41436-021-01129-6. This article has 30 citations and is from a highest quality peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Differential Diagnoses

Source YAML

References & Deep Research

References

Deep Research

PRR12-Related Neuroocular Syndrome: Disease Characteristics Report

Executive summary and evidence scope

1. Disease information

Definition and names

Identifiers

2. Etiology, risk, and protective factors

3. Phenotypes

Neurodevelopment

Eye and visual system

Multisystem findings

4. Genetic and molecular information

5. Environmental information

6. Mechanism and pathophysiology

Evidence-supported causal chain

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

11. Outcomes and prognosis

12. Treatment and current applications

13. Prevention

14. Other species and natural disease

15. Model organisms and research priorities

Overall assessment

Artifacts